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ABSTRACT 
 Biochemical endpoints are useful when determining contaminant exposure in 
aquatic organisms.  However, behaviors can also be impaired by environmental 
contaminants.  Links between changes in brain biochemistry and behavior have been 
made, and understanding these relationships could increase the utility of these endpoints 
in ecological risk assessments.  The overall goal of this research was to determine 
relationships between an ecologically relevant fish behavior and brain biochemistry.  To 
accomplish this goal, I developed a behavioral bioassay that quantified the time it took 
exposed hybrid striped bass (Morone saxatilis x M. chrysops) to capture unexposed prey, 
fathead minnows (Pimephales promelas).  Chemically targeted brain neurotransmitters 
were also monitored, and the relationship with behavior was determined.  
Six-day acute exposures to (1) a pesticide (diazinon) targeting 
acetylcholinesterase (AChE) and (2) a pharmaceutical (fluoxetine) targeting serotonin 
were conducted with a 6-day recovery periods.  Brain biochemistry and behaviors were 
plotted against each other.  Our results indicated that there was a threshold response 
between AChE activity and feeding behavior following diazinon exposure concentrations 
of 19.1 ± 0.7, 64.0 ± 2.0, and 101.9 ± 1.4 µg/l.  By day 6, AChE activity was significantly 
inhibited in the low, medium, and high treatment groups by 66.3, 82.2, 86.4%, 
respectively.  However, there were no signs of behavioral impairment in the lowest 
treatment group.  During the 6-day recovery period, there were concentration- and 
duration-dependent changes in feeding behavior and AChE activity, in which time to 
capture prey decreased more rapidly than AChE activity increased.  Following fluoxetine 
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exposures (23.2 ± 6.6, 51.4 ± 10.9, and 100.9 ± 18.6 µg/l), a linear response between 
decreased serotonin activity and increased feeding behavior was observed.  However, 
maximum serotonin depression in the low, medium, and high treatment groups occurred 
on day 9 (day 3 of the recovery period) with concentrations at 23.7, 28.0, and 49.1% of 
controls, respectively.  Our results also indicated that during the recovery period, there 
was a concentration- and duration-dependent increase in serotonin activity accompanied 
by a decrease in time to capture prey. 
A 27-day chronic exposure to fluoxetine was also conducted at lower exposure 
concentrations (0.08 ± 0.02, 0.87 ± 0.12, 9.44 ± 0.82 µg/l) than the acute exposure.  It 
was concluded that although fluoxetine can cause impaired serotonin levels and feeding 
behavior, this was not observed at more environmentally relevant concentrations over the 
27 days.    
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PREFACE 
Brain biochemistry can affect an organism‟s behavior, the interaction between 
individuals, and ultimately the success of the entire population.  Many environmental 
contaminants affect the nervous system including brain chemistry.  These contaminants 
find their way into surface waters where they pose a risk to aquatic organisms, including 
fish.  However, few researchers have quantified the relationship between brain chemistry 
and fish behavior. Such a relationship could be very useful in ecological risk assessment 
including making biochemical markers more ecologically relevant. While many 
researchers have quantified the response of biochemical or behavioral endpoints to 
sublethal chemical stress, few have attempted to establish a relationship between the two. 
This dissertation consists of a literature review and three journal articles.  The 
literature review discusses the connection between brain biochemistry and behavior, 
environmental contaminants that can act on the nervous system, and behavioral bioassays 
used to as tools for measuring effects of environmental stressors.  The first journal article 
(Chapter 2) describes effects of a 6-day diazinon exposure followed by a 6-day recovery 
period on acetylcholinesterase activity and prey-capture in hybrid striped bass.  The 
second journal article (Chapter 3) describes the effects of 6-day fluoxetine exposure 
followed by a 6-day recovery period on serotonin and prey capture in hybrid striped bass.  
The final journal article (Chapter 4) evaluates the effects of a longer fluoxetine exposure 
(27-day) on monoamine levels and prey capture in hybrid striped bass using lower 
concentrations than in the 6-day exposure detailed in Chapter 3. 
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CHAPTER 1: LITERATURE REVIEW 
Connecting Brain Biochemistry and Behavior in Toxicology 
In the past few decades, there has been an increase in research characterizing 
various biochemical endpoints.  While these endpoints are easily correlated with 
organism exposure, they are not used as often in risk assessments because their ecological 
relevance is not as well defined.  They have not yet been linked directly to impacts at the 
organism level, let alone at the population and community levels [1]. Therefore, 
correlating behavioral and physiological changes is an important research focus because 
it could enhance the prediction of population-level responses from biomarker data. 
Behaviors are the result of genetic, biochemical, and physiological processes [2] 
that operate through the central nervous system (CNS) permitting an animal to exist in an 
optimal environment [3].  Changes in behaviors critical to organism survival (habitat 
selection, competition, predator avoidance, prey selection, and reproduction) can be 
induced through direct effects to the nervous system or indirect physiological alterations 
[2].  Therefore, it is important to know the relationship between biochemical and 
behavioral endpoints before we can fully determine the ecological relevance of change in 
either.  
A major objective of the behavioral sciences is to characterize behaviors and 
identify the circumstances that bring it about and the consequences that change it [4].  
Behavior provides a unique perspective between organisms and their environment and 
can be crucial for developing mechanistic causes of contaminant effects.  In turn, 
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understanding the mechanisms responsible for these changes could serve as a valuable 
guide to further interpret behaviors [4,5].  
Since behavior is regarded as the net output of the sensory, motor, and cognitive 
function in the nervous system, it can be a sensitive endpoint of chemical-induced 
neurotoxicity [6].  There are numerous sites of action for toxicants to affect the nervous 
system, so interference at any of these sites could block or alter the sequence of neural 
responses and inhibit or alter behavior [2].  Neurotoxicity has been defined as „any 
adverse effect on the structure or function of the central and/or peripheral nervous system 
produced by chemical exposure‟, and exposure to neurotoxicants can result in sensory, 
motor, and cognitive dysfunction [6]. Thus, behaviors could also be impaired as a result 
of contaminant exposure and techniques have been derived from experimental neurology 
to detect and characterize such changes.  However the degree of change can be dependent 
upon the chemical(s), concentration, and duration of exposure. 
Ecological Relevance of Behavior 
The effects of environmental contaminants can be studied at the biochemical and 
cellular levels, organismal level, and population or community level [7].  Each level of 
organization is important because they typically carry out different operations [4].  Many 
times we look at biochemical biomarkers because they are useful as early warning signs 
of chemical exposure [7], but it can also be assumed that changes at lower levels of 
organization could escalate to community level effect if left unabated [7].  Therefore, 
since behavior is an individual-level response having clear links to biochemistry and 
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population dynamics, changes in behavior could be an ecologically relevant endpoint for 
monitoring environmental stress.  
Ecological fitness 
Ecological fitness can include an organism‟s ability to find food and shelter, avoid 
predation, and reproduce.  Ultimately, these behaviors are critical to the population.  
Behavioral responses are important for survival and ecological fitness because they are 
necessary for performing essential life functions like habitat selection, competition, 
predator avoidance, prey selection, and reproduction [2].  Unfortunately, environmental 
pollutants can pose serious risk to many aquatic organisms [5] altering normal behaviors, 
which could impair survival of an organism or the population.   
Traditionally, regulatory guidelines for aquatic pollutants in natural ecosystems 
have been based on acute lethality tests like the 96-h LC50, but impacts on development, 
growth, and reproduction are also frequently studied [5].  While the development of 
water-quality criteria has often relied heavily on chemical concentrations causing 
mortality and impaired growth in laboratory exposures, this may not be the best predictor 
of impacts in the field when organisms are exposed to sublethal concentrations [3].  
Acute tests useful for generating guidelines for preventing physiological death tend to 
ignore ecological death that could occur at sublethal concentrations of toxicants [5].  
Therefore, behavioral indicators of toxicity may be ideal for assessing sublethal impacts 
of exposure [5] because many times, behavioral changes can occur before death with 
sublethal concentrations. While they may seem to be unharmed, organisms may be 
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unable to function normally [5] so by testing ecologically relevant behaviors, we can get 
a better idea about ecological fitness and effects at the population and community levels. 
Population implications 
Since environmental contaminants can elicit a wide variety of biochemical 
responses and adverse effects in an organism‟s behavior, reproduction, and development, 
it can be hypothesized that there may also be population level impacts in multiple species 
or in ecosystems [8].  While chemicals affect individual organisms, the ultimate level of 
concern may be the population or community level.  Many times, the fate and effect of 
environmental toxicants has been studied with the aim of understanding how the structure 
and functioning of populations, communities and ecosystems are affected [9].  
There are many factors to consider when assessing the impacts of an 
environmental contaminant.  Dose, body burden, duration, and timing of exposure at 
critical life stages (age and development period) are all important considerations for 
assessing the adverse effects [8,10].  Many times effects are delayed and are not fully or 
obviously expressed until offspring reach maturity or middle age, even though critical 
exposure may have occurred during early embryonic, fetal, or neonatal life [10]. In 
addition, effects may be reversible or irreversible, immediate (acute) or latent (not 
expressed for a period of time) [8].  Therefore, toxicological effects observed within 
individual organisms do not necessarily all have the same potential to impact populations, 
nor should it be expected that effects would elicit population responses at the same 
exposure levels [8].   
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Environmental Contaminants and the Nervous System 
There are a wide variety of contaminants released into the environment from 
residential, commercial, and industrial sources that can be toxic to people, fish, wildlife, 
and plants.  Many of these contaminants may not be deadly at the levels found in the 
environment, but can possibility interact with the nervous system and cause adverse 
effects. Many toxic chemicals including metals, PCBs, PAHs, pesticides, and 
pharmaceuticals can affect either the central or peripheral nervous system [11] and 
cellular metabolism. 
Pesticides  
Classes 
There are number of different types of pesticides that are available for use and 
have been classified as algaecides, bactericides, fungicides, herbicides, insecticides, and 
rodenticides, depending on the target pest.  They are used for preventing, controlling, or 
lessening the damage caused by pests, and have mainly been used to protect crops.  In 
this discussion, I will focus on insecticides, and more specifically, organophosphates and 
carbamates. 
There has been a major shift in insecticide use from organochlorine (OC) 
compounds to organophosphorous (OP) and carbamate (CB) insecticides.  The use of 
OCs in the U.S. began in the 1940s until the 1970s when most uses were banned or 
severely restricted when potential human health concerns and adverse ecological effects 
became apparent.  In addition, OC insecticides (especially DDT) were resistant to 
degradation and have long environmental half-lives, causing harm long after their ban.  
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One reason OP and CB insecticides were favored for replacing OCs was that while they, 
too, are highly toxic, they are considered to have relatively short half-lives (2-4 weeks) 
and are readily metabolized and excreted [12, 13].   
There are about 200 OPs and 50 CBs formulated into thousands of products 
available around the world for use in wetlands, rangelands, cultivated crops, forests, and 
rural and urban settings. However, 95% of OP products are used for agriculture and 
mosquito control [13].  OP insecticides came into wide-scale use in the US in the late 
1960s and 1970s.  By the late 1980s, they made up more than one third of registered 
pesticides [13] and accounted for approximately 65% of total insecticide use with seven 
of the top 11 insecticides used (in terms of mass applied) being OPs [12]. OPs widely 
used in the US included chloyprifos, malathion, methyl parathion, parathion, fenthion, 
and diazinon.  However, some of these chemicals have been reviewed by regulatory 
agencies for environmental and public health concerns and are now classified as 
restricted-use pesticides in the US.  While some OPs that have had most uses withdrawn 
or cancelled in the US, they may still be available in other countries despite their 
environmental concerns [13].  In addition, only eight of the 50 CBs are used for insect 
control on crops, forests, and rangelands and out of these eight, carbofuran, methomyl, 
and carbaryl account for more than 90% of the use [13]. 
Sources of Exposure 
Pesticides are purposely introduced into the environment for many purposes 
including agriculture, forestry, transportation (weed control along roadsides and 
railways), household, and various commercial and industrial uses [12].  While 
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nonagricultural uses can be substantial in some areas, the majority of pesticide use (70-
80%) has been for agricultural purposes [12].  Agricultural application practices include 
aerial spraying, near-ground spraying from a tractor, soil incorporation, chemigation, and 
direct application to plant foliage [12].  Except for mosquito control, nearly all OP and 
CB application is on terrestrial landscapes [13].  There are, however, some pesticides that 
have been applied directly to surface waters for controlling algae, macrophytes, insects, 
and fish parasites, but these applications are usually carried out by federal, state, and 
local government agencies, or through permits issued by these agencies [12].  
In any case, it is believed that all pesticides may eventually enter an aquatic 
system, affecting a much larger number of species than originally intended [13].  They 
have been invariably detected in waters, soils, and vegetation outside the treated areas 
[13] as a result of applicator error, drift, runoff, or drainage induced by rain or irrigation 
[12].  Pesticides have been detected in every region of the United States where surface 
waters have been analyzed [12] and are present throughout most of the year in streams 
draining agricultural and urban watersheds; however, their occurrence does not 
necessarily cause adverse effects due to low concentrations (ng/L) detected [14,15].  In 
addition, OPs and CBs are comparably labile in the environment and do not 
bioaccumulate or biomagnify to any important degree in aquatic or terrestrial food chains 
[13]. 
Four main factors affect pesticide transport in runoff.  First are rainfall intensity, 
duration, amount, and timing with respect to pesticide application.  Second are soil 
texture, organic matter content, water content, and slope and topography of the field.  
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Third are physical and chemical properties of the pesticide including water solubility, 
acid/base and ionic properties, sorption properties, and persistence.  Finally are 
agricultural management practices including pesticide formulation, application rate and 
placement, erosion control practices, plant residue management, use of vegetative buffer 
strips, and irrigation practices [12].  
Pharmaceuticals 
Classes 
Each year the US Food and Drug Administration (FDA) approves several new 
drugs that are classified under different categories including estrogens for contraceptives 
and hormone replacement, analgesics (painkillers), non-steroidal anti-inflammatory 
drugs, antibiotics, anti-cancer drugs, blood-pressure medications, and antidepressants.  
Nicotine and caffeine are also considered to be drugs.  In general, these medical 
substances can be divided into two groups: (a) medical substances used by humans and 
(b) veterinary medicines.  While classes of human use drugs have been mentioned, 
veterinary medicines for domestic animals, poultry and livestock, and fish farms can also 
include antimicrobials/parasitics, hormones, non-steroidal anti-inflammatories, 
antidepressants, CNS agents, gastrointestinal agents, and cardiovascular agents [16]. 
Sources of Exposure 
Drugs are similar to pesticides with regard to their contribution to water pollution, 
but unlike regulated pesticide disposal, drug disposal has not been regulated.  Little is 
known about the extent of environmental occurrence, transport or ultimate fate after their 
intended use, yet just about every class of pharmaceutical has been identified in the 
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environment [17].  Sources of contamination include production facilities, hospitals, 
private households, veterinaries, agricultural farms (livestock, poultry, and fish), and 
wastewater treatment plants [18].  While the occurrence of pharmaceuticals and personal 
care products (PPCPs) in the environment is not a new phenomenon, it has only become 
more widely evident in the last decade as a result of continually improving chemical 
analysis methodologies with lower limits of detection for a wide array of xenobiotics 
[19]. 
PPCPs can be inadvertently released to the environment directly (disposal and 
wastage from external application) or indirectly (excretion, washing, and swimming). But 
municipal sewage (treated and untreated) is the major source for most drug classes and 
quantities [19].  Wastewater treatment plants (WWTPs) can process and remove most 
chemicals, but many pharmaceuticals are not fully removed [17, 20].  As a result, WWTP 
effluent has been a significant contributing source of pharmaceuticals in receiving 
streams.  One reason is that drugs tend to be hydrophilic in order to pass through cell 
membranes [16].  This would require different treatment technologies for removal from 
wastewater than many other pollutants which tend to be somewhat hydrophobic.  While 
effective wastewater treatment methods are being researched, reverse osmosis and 
granular activated carbon have been valuable in removing certain classes of 
pharmaceuticals from water. Unfortunately, implementing these technologies can be 
extremely expensive leaving drugs to flow continuously into waterways.  But the fact that 
pharmaceuticals can be continually introduced to the aquatic environment (even at low 
concentrations) creates a sense of „persistence‟ of compounds that otherwise many not be 
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environmentally stabile creating a chronic exposure scenario [20-22].  It has also been 
found that some drugs could be detected in fish tissue samples where the stream was 
almost entirely comprised of effluent discharge [21]. 
Terrestrial runoff from confined animal feeding operations, excreta from 
medicated pets and livestock, overflow or leakage from storage structures and wind-
borne drift of agriculturally applied antimicrobials to crops have been additional sources 
of pharmaceutical contamination of terrestrial and aquatic environments [17, 19].  
Medical substances used in fish farms have also been directly applied to receiving waters 
since the most convenient method of treating fish with antibiotics and chemotherapeutics 
is by the use of feed additives.  Typically, large portions of medicated feed are not 
consumed, resulting in potential sediment accumulation affecting other aquatic organisms 
[16].   
Neurotransmitters of Interest 
The mammalian nervous system has over 30 substances classified as 
neurotransmitters identified.  Neurotransmitters are chemical messengers that relay, 
amplify, and modulate signals between a neuron and another cell across a synapse [23].  
This includes acetylcholine, amino acids (glycine and glutamate), and biogenic amines, 
which are products of amino acid decarboxylation  (dopamine, norepinephrine, 
epinephrine, -aminobutyric acid, histamine, and serotonin). 
Acetylcholine 
The role of the neurotransmitter acetylcholine (ACh) in the firing of cholinergic 
synapses between motor neurons and skeletal muscle cells is well known.  Acetylcholine 
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is present in somatic and autonomic motor neurons in the spinal cord and brain stem, in 
autonomic (parasympathetic) ganglia, and skeletal muscles [24].  It is a quaternary amine 
synthesized by the binding of choline to acetyl-coenzyme A by the enzyme choline 
acetyltransferase.  Binding of ACh opens cation channels (mainly Na
+
) in skeletal muscle 
cells, eliciting an action potential that spreads out in multiple directions to signal muscles 
to contract.  In cardiac muscle fibers however, ACh can decrease contraction, likely due 
do differences in receptor structures [24]. 
One of the most commonly observed indicators of neural function is brain 
acetylcholinesterase (AChE).  Acetylcholinesterase is responsible for 
degrading/hydrolyzing ACh to end cholinergic neural transmission and prevent ACh 
accumulation in and around a synapse [5, 25].  Located on post-synaptic membranes, 
AChE plays an important role in regulating nerve impulse transmission at cholinergic 
synapses.  Once ACh is broken down to acetate and choline by AChE, choline is taken 
back up into the nerve terminal by high affinity transporter proteins [24].  This is one of 
the most important factors in regulating the synthesis of ACh [24].  Since ACh molecules 
involved in a nerve impulse must be degraded in the few milliseconds before the potential 
arrival of the next nerve impulse [26], AChE plays a significant role in this process.  A 
single AChE molecule can break down 5,000 ACh molecules to choline and acetate 
following their release into the synapse [24]. 
Serotonin 
Serotonin is found thorough out the body in blood platelets, mast cells, and 
chromaffin cells in the gut; but serotonergic neurons are found almost exclusively in a 
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group of nuclei near the midline of the brain stem reticular formation, called the raphe 
nuclei [24].  Serotonin is a neurotransmitter involved in the transmission of nerve 
impulses, synthesized from the amino acid, tryptophan.  Tryptophan is converted to 5-
hydroxytryptophan (5-HTP) by the enzyme tryptophan-5-hydroxylase.  Next, 5-HTP is 
converted to serotonin (5-hydroxytryptamine, 5-HT) by 5-hydroxytryptophan 
decarboxylase [24].  While the main metabolite of 5-HT is 5-hydroxyindoleacetic acid 
(5-HIAA), via aldehyde dehydrogenase or monoamine oxidase, 5-HT can also be 
converted to melatonin by 5-hydroxyindole-O-methyltransferase.  
Like other neurotransmitters, 5-HT is released from the presynaptic cell and can 
bind to receptor proteins on both the pre- and post-synaptic cell. It can change the 
electrical state of the cell by exciting the cell, passing along the chemical message, or 
inhibiting it.  Neurotransmitter action can be stopped by diffusion out of the synaptic cleft 
or through enzymatic degradation by monoamine oxidase (MAO) or catechol-O-
mehtyltransferase (COMT) [27].  Present in the synaptic cleft and presynaptic nerve, 
MAO and COMT deactivate neurotransmitters making them unrecognizable by the 
receptors [24].  But under normal circumstances, the principle mechanism of signal 
inactivation is transporter-mediated uptake of monoamines from the synapse back into 
the presynaptic cell where they are reprocessed [28]. 
Transporter proteins in the membrane of nerve terminals put an end to transmitter 
action and control extracellular concentrations of monoamines.  The task of transporters 
is not to remove all traces of neurotransmitters from the extracellular fluid, but rather to 
regulate a baseline concentration [24].  Since secretion and elimination of serotonin is 
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highly regulated, there are mechanisms in place for controlling moderate fluctuations via 
negative feedback control [8]. Autoreceptors located on the pre-synaptic membrane can 
modulate transmitter release as a kind of negative feed back control [24].      
Since serotonergic neurons have axons that project to many different parts of the 
brain, 5-HT affects several behaviors [29].  Serotonin is involved in the control of 
appetite, sleep, learning and memory, temperature regulation, mood, behavior (aggression 
and dominance), cardiovascular function, muscle contraction, endocrine regulation, and 
depression.  It has also been implicated in the central control of regulation of circadian 
rhythm, cognitive ability, reproduction/sexual behavior, memory, and attention [29-32]. 
Mechanisms  
Acetylcholinesterase Inhibitors 
The principle toxicity of organochlorine and carbamate insecticides is based on 
nervous system disruption by inhibition of cholinesterase activity in the CNS and at the 
neuromuscular junctions [13]. For example, OPs interact with a hydroxyl group on 
AChE, which is a functional part of the enzyme.  Once phosphorylated, AChE has no 
activity [23].  While the mode of action is similar for OP and CB pesticides, there are 
many differences between these classes.  One difference is the faster onset of acute 
toxicity by CBs as a result of direct ChE inhibition, whereas most OPs must first undergo 
an oxidative desulfuration step for maximum potency [13].   
Secondly, unlike OPs, CBs are considered to bind reversibly allowing 
cholinesterase to become reactivated.  However, it is possible for AChE levels to recover 
following OP exposure, but the inhibitory effects on AChE activity lasts longer than the 
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original exposure [33, 34].  A rapid recovery within a few hours may follow CB 
exposure, but it may take 1-3 weeks for AChE recovery following a single OP exposure 
[13].  However, the time it takes for AChE levels to fully recover is dependent on the rate 
of new enzyme synthesis, species, type and concentration of OP, and overall degree of 
AChE inhibition [35-37].  Therefore, cumulative depression of AChE may occur and 
persist from repeated exposure to some OPs, but generally not with CBs.   
When OPs bind to ChE, a relatively stable bond is formed preventing deactivation 
of acetylcholine, and thus permitting a buildup of ACh and an overstimulation of the 
cholinergic nervous system.  If this disruption is prolonged, the system for relaying 
impulses across the post-synaptic membrane becomes rundown, leading to synaptic 
block.  This causes muscle rigidity from continual stimulation and can lead to paralysis 
and possibly death due to respiratory failure [23, 38, 39].  Following a sublethal 
exposure, carbohydrate metabolism, reproduction, and behavior can also be impaired 
[38].  
OP and CB insecticides have a broad-spectrum toxicity and the relationship 
between depressed AChE activity and behavior has been studied in many species ranging 
from invertebrates to mammals [23].  There are considerable differences across species in 
the degree of AChE inhibition that can be tolerated without physiological impairment, 
which are attributed to variations in rates of uptake, detoxification, activation, and/or 
excretion [25, 35, 38, 40].  The degree of AChE inhibition is also dependent upon which 
insecticide the organism is exposed to [34, 38, 41, 42], exposure concentration [43] and 
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exposure duration [44].  Organism age can also be a factor affecting the degree of AChE 
inhibition [45].   
Overall, it appears that a 70-80% decrease in brain AChE activity can be tolerated 
before death occurs in fish, so care should be taken when interpreting results of AChE 
measurements in fish brains because this may not be the ultimate „cause of death‟ [25].  
This interpretation must consider the fact that the test chemical often acts on a variety of 
points in the endocrine and nervous systems simultaneously.  Mortality may be due to 
inhibition of other enzymes, especially those taking part in carbohydrate and protein 
metabolisms, rather than just AChE inhibition [46].  Pesticides may also cause oxidative 
stress in an organism, leading to the generation of reactive oxygen species at levels 
surpassing antioxidant defenses.  This could, in turn, result in harmful effects on DNA, 
proteins, and lipids [46]. In addition, sublethal doses of diazinon has been shown to 
negatively affect blood stream estradiol levels [47] and testis structure [48] of bluegill, 
which could potentially impair reproductive success.  
Brain neurotransmitter levels and enzyme activity correlate well with behavioral 
states [5].  Many researchers have considered the relationship between brain AChE 
activity and various behaviors including swimming [42, 38, 49-51] and foraging/feeding 
[33, 52].  Sometimes there were linear relationships between changes in behavior and 
AChE, but many times there were significant decreases in AChE activity before behavior 
responses were noted [39].  Whether a linear relationship or a threshold response is noted, 
changes in behavior could eventually alter an organism‟s ecological fitness leaving it 
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more susceptible to predation, less efficient at capturing prey, or unable to successfully 
court or reproduce.  These effects could ultimately affect the population. 
Selective Serotonin Reuptake Inhibitors (SSRI) 
As stated previously, serotonin is involved in controlling a number of behaviors.  
It has been shown that decreased levels of synaptic serotonin (5-HT) and/or 
norepinephrine (NE) can give rise to depression, obsessive thoughts, and a lack of 
impulse control.  Therefore, drugs like selective serotonin reuptake inhibitors (SSRIs), 
selective norepinephrine reuptake inhibitors (SNRI), and selective serotonin and 
norepinephrine reuptake inhibitors (SSNRI) were developed to lessen these ailments [28].  
Reuptake inhibitors elicit their effect of increasing levels of specific monoamines at the 
synapse by interacting with, and binding to, monoamine transporters in the CNS, without 
being transported themselves [28].  By blocking transporters in inhibiting the recapture of 
neurotransmitters from the synapse, extracellular 5-HT and/or NE concentrations can 
become elevated [53]. 
SSRIs have a high affinity to 5-HT uptake sites, low affinity to NE uptake sites, 
and even lower affinity for neurotransmitter receptors [53].  Inhibition of 5-HT reuptake 
transporters promotes 5-HT neurotransmission, but autoreceptor activation could signal a 
decrease in neurotransmission once high levels of 5-HT are recognized [54].  Therefore, 
although transporters are blocked immediately following administration of reuptake-
inhibiting drugs, it is believed that the 2-3 week delay in noticeable therapeutic effects 
(increased 5-HT levels) is attributed to autoreceptor activation [55].  Many studies have 
shown that chronic SSRI treatment eventually leads to the functional desensitization of 5-
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HT1A autoreceptors on serotoninergic cells, allowing serotonergic neurotransmission to 
occur in the presence of the drug and high extracellular 5-HT [55, 56]. Thus, therapeutic 
effects were felt when extracellular 5-HT levels increased. 
The use of SSRIs has been rapidly increasing and they have become a focus for 
environmental researchers following their detection in the environment [57].  Brooks et 
al. [58] evaluated the acute effects of fluoxetine on algae (Pseudokirchneriella 
subcapitata), Ceriodaphnia dubia, Daphnia magna, Pimephales promelas, Hyalella 
azteca and Chironomus tentans, while Henry and Black [59] looked at the effects on 
western mosquitofish (Gambusia affinis).  All organisms were adversely affected by the 
fluoxetine exposure in the laboratory, however, the concentrations were at least an order 
of magnitude greater than those reported in municipal effluent. Other effects noted in the 
laboratory included developmental abnormalities in Japanese medaka (Oryzias latipes) 
with minimal effects on number of eggs produced, fertilized, or hatched when exposed to 
fluoxetine [60]; and increased spawning in zebra mussels (Dreissena polymorpha) [61], 
increased parturition in fingernail clams [62], and reduced mean number of neonates 
produced in Ceriodaphnia dubia [63] when exposed to various SSRIs. 
Exposure duration could play just as much a role in the effects of fluoxetine 
exposure as the exposure concentration, especially considering the role of autoreceptors 
in regulating neurotransmission.  It is possible that initially, SSRI exposure could lead to 
decreased 5-HT levels from activation of autoreceptors; but prolonged exposures could 
cause autoreceptor desensitization allowing for 5-HT levels to increase. Therefore, 
measuring 5-HT levels along with other endpoints may be important since both increases 
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and decreases in these levels have been noted depending on the species and duration [54].  
For example, it was found that a 7-day fluoxetine exposure reduced Pimephales promelas 
feeding rates in a dose dependent manner, but a 21-day fluoxetine exposure increased 
Daphnia magna grazing rates, though not significantly [64].  These results could reveal 
an effect of exposure duration and/or species variability, but the authors did not measure 
serotonin levels, nor did they monitor feeding/grazing over the course of exposure.  
Therefore, aside from behavioral observations, no real conclusion can be drawn on 
biochemical changes as a result of the exposure or the duration. 
Many behavioral studies evaluating the effects of SSRIs on aquatic organisms 
have not compared 5-HT levels with observed behavioral changes.  It has been usually 
assumed that serotonin levels increased regardless of what is know about the delayed 
therapeutic effect of SSRIs.  However, this may not always be a correct assumption.  For 
example, a behavioral study with Betta splendens showed decreased territorial aggression 
following acute treatment with 5-HT [65].  This suggested that increased 5-HT levels 
lead to decreased aggression.  Therefore, since the goal of SSRIs is to increase 5-HT 
levels, it may be assumed that fluoxetine exposure would also decrease aggression.  
However, when Betta splendens were exposed chronically to fluoxetine, they neither 
exhibited significantly decreased aggression nor increased serotonin levels [65].  Instead, 
Clotfelter et al. [65] found that the exposure reduced serotonin and 5-HIAA levels, which 
is actually consistent with long-term exposures for a number of rodent studies.  This 
again supports the importance of exposure duration when interpreting the effects of 
reuptake-inhibiting drugs.  
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Behavioral bioassays 
Behavioral toxicity occurs when a contaminant or other stressor induces changes 
that exceed the normal range of variability [2].  Sometimes, this can be observed at levels 
much lower than the LC50.  A single behavioral parameter can be more comprehensive 
than a physiological or biochemical parameter, but behavioral bioassays have still not 
reached the stage where they are fully accepted as part of formal testing procedures [23].  
The extent to which behavioral studies could be used in risk assessment depends on the 
validity and understanding of the biochemical effect of the chemical [6].  Still, behavioral 
tests have been frequently used to identify and characterize chemical-induced alterations 
in endocrine and nervous system functions, and better predict exposure concentrations 
that impact ecological fitness - not just survival.  There are a number of behavioral assays 
developed to assess sublethal effects of environmental stressors in fish including 
reproduction, avoidance, schooling, aggression, swimming, predator avoidance, and 
feeding.  However, it should be mentioned that generalizations regarding any behavioral 
response to aquatic contaminants are difficult to make due to the variety of species and 
experimental designs used for each test [2]. 
The most described predictor of population level effects is to measure 
reproductive success [5].  Since reproduction is extremely important for population 
success, it is likely the most relevant for predicting ecological consequences of 
contamination [2].  Reproduction results from a variety of behaviors including migration 
to reproductive habitats, establishment of territories, reception and response to courtship, 
spawning, nest preparation and defense, and parental care [2].  Tests can be performed 
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for analyzing these behaviors/interactions along with other reproductive measurements 
like time-to-maturation, population sex ratios, expression of secondary sexual 
characteristics, clutch size, and percent hatch/survival. Impairment of any of these 
behaviors could reduce reproductive success and ultimately harm the population.   
Many contaminants can also induce avoidance responses.  This behavioral 
response has been observed for over 80 years [23].  Avoidance of unfavorable habitats 
can be induced by a contaminant, but the opposite could also occur.  If a chemical attracts 
an organism, it could leave it vulnerable to injury or death [2].  This response can be 
measured by assessing habitat selection of treated and untreated organisms.  Treated 
organisms could be more inclined or less inclined to avoid unfavorable conditions, or less 
responsive to present danger (i.e. predators, extreme temperatures) [2].  However, pre-
exposure to a contaminant could skew responses, leading to an acclimation or 
desensitization to the chemical(s).  This could lessen the behavioral response and 
underestimate the concentration that would elicit such a response [23].   
Social interactions among fish such as schooling and aggression can also be 
impaired by environmental contaminants.  Schooling is highly evolved among fishes for 
increasing habitat surveillance and providing protection from predators [2].  Many 
contaminants impair the schooling behavior of fish so some methods for measuring 
schooling behavior include measuring distance between individuals, orientation within a 
school, and latency with which the school forms or tighten [2].  Methods for measuring 
aggression include monitoring changes in posture or coloration, and movement toward or 
contact between conspecifics [2].  Competition among individuals, species, or age classes 
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can occur when resources needs overlap, making aggression necessary for survival.  
Therefore, the more aggressive organism will be further ecologically fit with the 
capability to win food, shelter, or a mate [2]. 
Swimming behavior is another fundamental behavior that can be disturbed by 
environmental contaminants.  This behavior is extremely important because it is 
fundamental to feeding, competition, predator avoidance, and reproduction [2].  
Swimming includes frequency and duration of movements, speed and distance traveled, 
frequency and angle of turns, position in the water column, form and pattern of 
swimming, orientation to water flow, and the capacity to swim against a current [2].  
Since many of these variables are interrelated, they can be measured simultaneously. 
Swimming behaviors, like other behaviors, vary across species and life stage, so test 
methods must be tailored accordingly [2]. 
An altered ability to detect or respond to predators can increase an organism‟s 
vulnerability to predation.  Therefore, predator avoidance is another useful behavioral 
measurement of environmental stress and can be measured by subjecting equal numbers 
of exposed and unexposed prey to a predator under ideal conditions and observing which 
prey population is more susceptible to predation.  While this can be useful for 
determining effective concentrations, the link between contaminant exposure and 
predator avoidance is not as straightforward.  Sometimes exposed prey may become 
inactive or have reduced mobility making them less obvious to a predator, thereby 
making the unexposed prey more obvious [2]. 
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Feeding behaviors are important for development, fitness, and long-term viability 
of an organism [2].  There are multiple aspects of feeding that can be impaired by 
environmental stressors and contaminants leading to reduced growth and survival.  These 
include abilities for foraging, detecting, pursuing, capturing, and consuming food.  
Methods for measuring these behaviors include orientation to food, movement toward 
and striking activities, prey selectivity, feeding efficiency (number of prey attacked and 
captured), prey-handling time, strike and capture frequency (including spits and misses), 
and reaction distance [2].  Although there are numerous methods for measuring changes 
in feeding in several species, many of these behaviors are interconnected, so measuring 
multiple aspects of feeding is possible within a single test design [2]. 
The goal of this dissertation was to better characterize the relationship between 
brain chemistry and behavior in hybrid striped bass.   This goal was achieved through the 
following objectives: 
1.  Characterize the changes in predatory behavior as a function of reduced brain 
acetylcholinesterase caused by diazinon exposure. 
2.  Characterize the changes in predatory behavior as a function of reduced brain 
serotonin caused by short-term exposure to fluoxetine. 
3.  Characterize the changes in predatory behavior and brain serotonin associated 
with long-term exposure to fluoxetine. 
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CHAPTER 2: BEHAVIORAL AND BIOCHEMICAL EFFECTS OF DIAZINON 
 IN HYBRID STRIPED BASS 
Abstract 
  The effects of environmental stimuli on biochemical processes may influence 
behavior. Environmental contaminants that alter behavior can have major impacts on 
populations as well as community structures by changing species‟ interactions.  One 
important behavior is the ability to capture prey.  We hypothesized that sublethal 
exposure to diazinon, an organophosphate pesticide, may lead to feeding behavior 
abnormalities in hybrid striped bass (Morone saxatilis x M. chrysops) through inhibition 
of brain acetylcholinesterase (AChE) activity.  This can potentially reduce organism 
survival by affecting its ability to find and capture food.  To test this hypothesis, bass 
were exposed to diazinon for six d, followed by a six-d recovery period in clean water.  
Brain AChE activity and the ability of bass to capture prey fathead minnows were 
measured every third day.  Exposed fish exhibited a concentration- and duration-
dependent decrease in ability to capture prey.  While bass in all diazinon treatment 
groups had significantly inhibited brain AChE activity, only the medium and high 
treatment groups showed a dose- and time-dependent increase in time to capture prey. 
Acetylcholinesterase activity also decreased in an exposure duration- and concentration-
dependent manner.  The AChE levels in exposed fish did not recover to control levels 
during the 6-d recovery period.  These results suggest that sublethal exposure to AChE-
inhibiting substances may decrease the ecological fitness of hybrid striped bass by 
reducing their ability to capture prey. 
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Introduction 
Pesticides are commonly found in the aquatic environment at concentrations that 
may impact aquatic life, especially in areas where watersheds are dominated by 
agriculture, urban, or mixed land uses ([1]; http://pubs.usgs.gov/fs/2006/3028).  
Organophosphate pesticides (OPs) can enter aquatic systems through multiple routes 
including accidental spillage, discharge of untreated effluents, spray drift, and surface 
runoff [2].  Once OPs make their way into aquatic systems, they can create potentially 
toxic environments for non-target species.  The mode of action for OPs is to inhibit the 
enzyme acetylcholinesterase (AChE). Acetylcholinesterase is responsible for removing 
the neurotransmitter acetylcholine from the synaptic cleft, thus inhibiting AChE can 
create an accumulation of endogenous acetylcholine in nerve tissues and effector organs 
[3], resulting in a continuous firing of nerve impulses.  This disruption of normal nervous 
system function can lead to convulsions, paralysis, and eventually death [4].  Inhibition of 
AChE activity has been used as a biomarker of exposure for OP toxicity in terrestrial and 
aquatic organisms [2].    
Diazinon is an OP that has been extensively used to control a wide variety of 
insects for domestic and agricultural purposes [5]; 
http://fl.water.usgs.gov/Gafl/Abstracts/ofr93478/ofr93478.html).  While there has been a 
significant decrease in environmental diazinon concentrations due to a phase-out for 
nonagricultural uses beginning in 2002 [1], diazinon has been frequently detected as high 
as 1.4 µg/L [6] in aquatic environments.  The presence of pesticides like diazinon could 
impair the ecological fitness of an organism by altering behaviors such as searching for 
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and capturing food, avoiding predators, and reproducing. Decreased fitness at the 
individual level could ultimately impact the population.  Because such behaviors are 
underlined by mechanisms at the biochemical level [7], assessing behavioral changes in 
organisms exposed to contaminants may allow researchers to better interpret biochemical 
changes as well as understand potential consequences at the population or community 
level.  
The purpose of the present study was to characterize the relationship between 
brain AChE and feeding behavior in hybrid striped bass (Morone saxatilis x M. chrysops) 
exposed to diazinon for 6 d followed by a 6-d recovery period.  Results of this study 
demonstrate a relationship between changes in brain biochemistry and an ecologically 
relevant behavior.  Understanding such a relationship is important because it allows us to 
better predict population level effects from a biochemical response. 
Methods and Materials 
Test chemicals 
Diazinon, acetylcholine iodide (ATCI), 5,5'-disthiobis(2-nitrobenzoic acid) 
(DTNB), and 0.1M phosphate buffered saline (PBS) were purchased through Sigma 
Aldrich (St. Louis, MO, USA).  Reagent grade NaHCO3 was purchased from Fisher 
Scientific (Fairlawn, NJ, USA).  
Fish 
Hybrid striped bass were chosen as the predator species because they grow 
rapidly, are resilient to handling stress, are amenable to laboratory culture, and are often 
stocked as sport fish and for use in aquaculture ([8], [9]; 
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http://www.lsuagcenter.com/en/communications/publications/newsletters/lagniappe/).  
Bass were obtained from Southland Fisheries (Hopkins, SC, USA).  Fish were housed in 
450 L circular flow-through holding tanks at Clemson University‟s Institute of 
Environmental Toxicology and fed a pellet food (Zeigler Brothers, Gardners, PA, USA) 
daily.  Larval fathead minnows (Pimephales promelas) were obtained from a culture 
maintained at Clemson University‟s Institute of Environmental Toxicology and reared 
until they were the appropriate size (~4 cm) to be used in the tests.   
Experimental design  
Hybrid striped bass were exposed to diazinon for 6 d under static conditions 
followed by a 6-d recovery period, for a total of 12 d.  Diazinon concentrations were 
tested at levels greater than those found in the environment in order to more clearly 
quantify potential impacts of diazinon on our chosen endpoints.  Four tests were 
conducted for periods of 3 d, 6 d, 9 d, or 12 d. The four treatment groups had five 
replicate bass per test, for a total of 20 bass per test.  Bass were fed live prey on days 0, 3, 
6, 9, and 12, and feeding behavior was quantified.  Fish brains were extracted for 
acetylcholinesterase activity at the end of each test (see below).  Hence, four tests were 
conducted for 3, 6, 9, or 12 d in which bass were fed every third day and brains were 
harvested at the end of each test.   
Hybrid striped bass (mean ± standard deviation [SD]; weight 166.0 + 37.3 g; 
length 21.4 + 2.3 cm) were randomly placed (one bass per tank) into twenty-four 80-L 
aquaria (30.5 cm x 30.5 cm x 90 cm) operated under flow through conditions (0.23 liters 
per min).  Bass that did not eat all four minnow prior to exposure initiation were 
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eliminated from the test to reduce any confounding factors.  Therefore, we stocked four 
extra tanks to be sure that there we would have 20 useable bass for a complete test.  Bass 
removed from the test were returned to the holding tank for potential use in subsequent 
tests. 
Bass were allowed to acclimate for 7 d prior to test initiation.  A nearby lake, 
Lake Hartwell (SC, USA), was the source of test waters (mean ± SD; pH 6.36 + 0.12, 
hardness 24 mg/L as CaCO3, alkalinity 10 mg/L as CaCO3). Water temperature was 
controlled using a mixing valve (M & M Control Services, Grayslake, IL, USA) that 
regulated a mixture of ambient and chilled water (ambient water circulated through an in-
line chiller) or heated water (ambient water circulated through an in-line heater) 
depending on the ambient conditions (summer or winter months, respectively) to 
facilitate achieving a desired temperature of approximately 25C (mean ± SD; 25.1 ± 
1.1C). Water was then pumped through a multi-resin filtration system (Water and Power 
Technologies Columbia, SC, USA) to remove suspended solids and any other possible 
contaminants prior to entering experimental tanks.  During exposure periods when waters 
were static, water temperatures were controlled by ambient air temperature.  Diazinon 
exposure lasted a maximum of 6 d under static conditions, followed by a maximum of 6 d 
for recovery (flow was turned back on at a rate of 0.23 liter per min), for a total of 12 d. 
 Bass were fed four fathead minnows every third day during the acclimation 
period.  This feeding regime ensured the bass were hungry and were accustomed to 
eating live minnows.  Bass were fed on days 1, 4, and 7 of the acclimation period so that 
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the last day of acclimating coincided with day 0 of the diazinon exposure.  Feeding 
behavior (time to capture prey) of bass was quantified every third day during the test. 
Prior to each feeding, air stones were removed from each tank, and water flow 
was also turned off during the recovery period.  Following this, researchers waited at 
least 2 min before adding prey for acclimation just in case bass were startled when air 
stones were removed.  Four fathead minnows were dropped into an exposure tank and the 
time to eat each prey was recorded.  Minnows used in the tests were visually estimated to 
be approximately 4 cm.  Minnows of similar size were preselected prior to feeding to 
ensure that no extremely large or small minnows were used to skew appetite satiation.  
Minnows were then randomly selected and fed to bass without regard to treatment. Bass 
were observed until all minnows were consumed or for a maximum of 25 min.  Any 
uneaten minnows after 25 min were removed from the tank, and air stones replaced.  
During the recovery period, water flows were also turned back on following each 
feeding. For statistical purposes, uneaten minnows were assigned a value of 1500 s (25 
min). 
Diazinon exposure 
At test initiation, water flow was turned off and an appropriate quantity of 
diazinon stock dissolved in acetone was added to each aquarium to achieve nominal 
treatment concentrations of 50, 150, and 200 µg/L.  While reported median effective 
concentration (EC50) and median lethal concentration (LC50) values for fish range from 
248 µg/L for bluegill (Lepomis macrochirus) to 6,970 µg/L for fathead minnows 
(Pimephales promelas) [10], preliminary studies performed in our laboratory found that 
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nominal concentrations of 300 µg/L resulted in significant deaths in hybrid striped bass 
following a 6-d exposure to diazinon.  Limited mortality in the highest treatment (200 
µg/L) slightly decreased the number of replicates for that treatment.  
One concentrated stock of diazinon was prepared for all tanks in order to reduce 
tank-to-tank variability within treatments. Final acetone volumes in each tank, which 
increased with increasing treatment level, did not exceed 280 µl in 80 L of water.  This is 
less than 0.0004% of the test water.  The Acetone Material Safety Data Sheet  (Fisher 
Diagnostic, Middleton, PA. www.cleanersolutions.org/msds/Acetone%20MSDS.htm) 
indicated the acetone LC50 for fish was greater than 5,000 mg/L.  Concentrations of 
acetone in our individual tanks of the present study did not exceed 2.8 mg/L. Previous 
research in our laboratory with a number of aquatic organisms has indicated that this 
concentration does not cause effects (S.J. Klaine, personal communication). Test waters 
were allowed to equilibrate for 1 to 2 h prior to taking 50 ml water samples for diazinon 
analysis.  These water samples were filtered through 6 ml C18 solid phase extraction 
columns (HyperSep C18, Thermo Electon, Bellefonte, PA, USA) that were 
preconditioned with 6 ml acetone, 6 ml methanol, and 6 ml deionized water.  Extraction 
columns were dried for at least 30 min at room temperature on a vacuum manifold (JT 
Baker, Philipsburg, NJ, USA) before eluting diazinon with ethyl acetate.  Control and 
low diazinon treatment samples were extracted in 10 ml ethyl acetate while the medium 
and high concentration samples were extracted in 25 ml.  Samples were stored at -20C 
until analyzed by gas chromatography.    
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 Diazinon half-life was previously determined to be approximately 48 h under test 
conditions.  Therefore, waters were spiked at half the original diazinon concentration on 
days 2 and 4 of the exposure period.  Water samples for diazinon analysis were taken on 
day 0, day 2 before spiking, day 2 after spiking, day 4 before spiking, day 4 after spiking, 
and day 6 to monitor fluctuating diazinon concentrations.  
Diazinon analysis  
Extracts (1µl) were analyzed via Hewlett-Packard 5890 gas chromatograph 
(Agilent Technologies, Santa Clara, CA, USA) with a flame photometric detector 
operated in „P‟ mode for 10.5 min each on a 5 meter HP-1  (100% dimethylpolysilozane 
coating) column (Agilent Technologies). Injection temp was 225C and the detector 
temperature was 200C. Oven was initially set at 60C, held for 0.5 min, then increased 
20C/min to 180C and held for 4 min. 
Brain tissue preparation 
Following timed feedings, bass were euthanized in buffered MS-222 (Tricaine 
methanesulfonate; Western Chemical Ferndale, WA, USA) and brains were quickly 
removed and put on dry ice prior to storage at -70C.  Brains were thawed, homogenized 
in 0.5 ml 0.1M PBS buffer, and diluted to 3 ml.  Homogenates were centrifuged at 5,000 
rpm and 4C for 20 min to remove cellular debris.  Supernatant was stored at -70C until 
used for bioassays. 
Protein assay  
Protein concentrations were determined using a BCA (bicinchoninic acid) Protein 
Assay Kit (Pierce, Rockford, IL, USA).  Brain homogenates were diluted 1:2 to 1:5 in 
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0.1M PBS prior to running the assay. Acetylcholinesterase activity was normalized using 
protein concentrations. 
Acetylcholinesterase assay 
Acetylcholinesterase analysis was modified from Ellman et al. [11]. 
Acetylcholine iodide was prepared at 21.68 mg/ml in 0.1M PBS.  Ellman‟s reagent was 
prepared at 3.96 mg/ml DTNB and 1.50 mg/ml NaHCO3.  The working buffer contained 
0.65% acetylcholine iodide (ACTI), 3.25% Ellman‟s reagent, and 96.10% 0.1M PBS.  
Four µl brain homogenate was added in duplicate in a 96-well plate to which 246 µl 
working reagent was added to all wells for a total of 250 µl per well.  Absorbance at 412 
nm was read in 5 min intervals over 30 min on a SpectraMax
®
 190 plate reader 
(Molecular Devices, Sunnyvale, CA, USA) using SoftMaxPro software (Molecular 
Devices).  
Data analysis 
We used Statistical Analysis Software
®
 9.1 (SAS, Cary, NC, USA) to analyze 
time to capture prey using a two-factor analysis of variance (ANOVA) model with the 
independent variables treatment and day.  Multiple pair-wise comparisons among and 
within treatment, day, and treatment-by-day terms were performed using the LSMEANS 
(least square means) option within PROC GLIMMIX (General Linear Model for Mixture 
Distributions), an analyses matrix that uses joint modeling for multivariate data. 
Acetylcholinesterase data were evaluated using two-factor ANOVA models with 
independent variables of treatment and day.  We used PROC GLIMMIX with 
LSMEANS statement to determine statistical differences among and within treatment, 
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day, and treatment-by-day interactions, rather than using PROC GLM (ANOVA 
analyses) with multiple MEANS and LSMEANS statements to determine significant 
differences among and within the independent variables.  An  = 0.05 was used as the 
level of significance for both time to capture prey and AChE levels with both PROC 
GLM and PROC GLIMMIX analyses.  
Results 
Diazinon concentrations  
Measured diazinon concentrations were approximately 40 to 50% of the 
anticipated nominal concentrations likely due to hydrolysis, photolysis, and some 
sorption to the aquaria and debris in aquaria.  Extraction efficiencies were 90 to 100% 
(data not shown).  Measured concentrations (mean ± standard error [SE]) throughout the 
exposure period for the low (50 µg/L), medium (150 µg/L), and high (200 µg/L) 
treatments were 19.1 ± 0.7, 64.0 ± 2.0, and 101.9 ± 1.4 µg/L, respectively.  These values 
represent the mean of all replicates of the four tests following each spiking.  Measured 
diazinon concentrations were used in all data analyses. 
Acetylcholinesterase  
Results from the present study showed a dose-response relationship between 
AChE inhibition and diazinon exposure concentration.  Brain AChE activities in all 
treatments were significantly different from each other at all time points after day 0 with 
the exception of day 12 (Figure 2.1).  Acetylcholinesterase activity continued to decrease 
significantly between days 3 and 6 for the low and medium treatment groups, but not the 
high treatment.  Hybrid striped bass in the present study demonstrated 86.4% AChE 
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inhibition (6.1 ± 0.6 pmol/mg protein/min) after just 3 d of exposure to the highest 
diazinon concentration (mean ± SE; 101.9 ± 1.4 µg/L) as compared to controls on that 
day (44.7 ± 4.1 pmol/mg protein/min), and these levels remained fairly constant through 
day 6 (5.6 ± 0.5 pmol/mg protein/min).  Acetylcholinesterase activity in bass in the low 
treatment (mean ± SE; 19.1 ± 0.7 µg/L) was decreased by 51.1% (21.9 ± 1.2 pmol/mg 
protein/min) and 66.3% (13.8 ± 1.6 pmol/mg protein/min) on days 3 and 6, respectively, 
while AChE activity in bass in the medium treatment (64.0 ± 2.0 µg/L) decreased by 
75.5% (11.0 ± 0.9 pmol/mg protein/min) and 82.2% (7.3 ± 0.3 pmol/mg protein/min) on 
days 3 and 6, respectively. 
Acetylcholinesterase activity began to increase during the recovery period in 
diazinon treated bass.  While AChE activity increased significantly by day 12 (day 6 of 
recovery) as compared to day 6, enzyme activities did not return to pre-exposure levels.  
By the third day of the recovery period (day 9), only AChE activity in bass in the medium 
treatment was significantly increased as compared to the end of the exposure on day 6.  
Acetylcholinesterase levels in the medium treatment increased by 8.3% between days 6 
and 9 to 10.1 ± 0.7 pmol/mg protein/min.  Brain AChE activities in low and high 
treatments on day 9 were only increased by 2.5% (14.1 ± 0.7 pmol/mg protein/min) and 
3.3% (6.6 ± 0.5 pmol/mg protein/min), respectively.  By the sixth day of recovery (day 
12) however, all treatment groups showed significantly greater AChE activity as 
compared to day 6. The low, medium, and high treatment groups increased by 20.3% 
(22.9 ± 1.2 pmol/mg protein/min), 13.4% (13.3 ± 1.9 pmol/mg protein/min), and 11.1% 
(10.5 ± 1.3 pmol/mg protein/min) as compared to day 6, respectively.   
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To determine the 6-d EC50 for AChE inhibition, diazinon concentrations were 
linearized using a log plot and 50% effect concentrations were calculated using the linear 
equation. The estimated 6-d EC50 was 15.2 ± 1.1 µg/L (Figure 2.2).  
Behavior Data: Exposure/Recovery Effects 
 On day 0, behavior data was recorded prior to initial diazinon exposure.  There 
were no significant differences among treatment groups.  At no time point during the test 
was feeding behavior in the low treatment significantly different from the controls 
(Figure 2.3) even though they exhibited significantly reduced AChE levels at all time 
points after day 0.  In the medium treatment, time to capture the first prey took 
significantly longer than controls on day 6 of the exposure period, and throughout the 
recovery period (days 9 and 12) (Figure 2.3a).  Time to capture the second prey fish was 
only significantly longer than controls on day 6, (Figure 2.3b), indicating that behavioral 
effects of diazinon were diminishing as recovery time increased.  However all time points 
for bass in the medium treatment for capturing the third prey fish were still significantly 
different from controls throughout the recovery period (Figure 2.3c).  Bass in the high 
treatment group took significantly longer to eat all prey fish versus the controls at all time 
points after day 0.   
As recovery time increased, time to capture prey decreased significantly for bass 
in the medium treatment, but not the high treatment.  Time to capture prey 1 and 2 in the 
medium treatment significantly decreased between the end of the exposure on day 6 and 
the third day of recovery on day 9.  While time to capture prey continued to decrease 
between days 9 and 12, this was not significant. During the recovery period (days 9 and 
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12), time to capture prey 3 for bass in the medium treatment was not significantly 
different from day 6.  While times to capture prey 1, 2, and 3 decreased for bass in the 
high treatment during the recovery period (days 9 and 12), they were not statistically 
different from day 6.  See Appendix Table A-1 for mean ± SE values for time to capture 
prey for each treatment and day. 
 Discussion  
Organophosphate pesticides have been widely used since the 1930s due in part to 
their rapid degradation in the environment [2]. As a result of their nonpersistence, it can 
be difficult to extrapolate an environmental concentration to behavioral or biochemical 
effects on aquatic organisms outside a laboratory scenario.  The specificity of OPs for 
AChE makes AChE activity a widely used biomarker of exposure to such compounds. It 
is important, however, that we try to establish links between biomarkers and higher levels 
of biological organization, notably ecologically relevant endpoints [12]. 
Changes in brain biochemistry can alter important behaviors for survival and 
fitness. While biochemical changes resulting from contaminant exposure are often cited 
as potentially detrimental, the implications of these changes on populations are 
speculative at best.  Organisms can compensate for sublethal stressors by altering energy 
uptake (feeding activity) and expenditure, which could lead to changes at lower 
biological levels and ultimately affect populations [12]. Therefore, an organism‟s feeding 
behaviors may provide a better indication of ecological fitness and the impacts of OP 
exposure on population dynamics [12] than biomarkers alone. Reduced feeding behavior 
can be separated into a number of different feeding processes including motivation, 
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orientation to prey, strikes, and miscues [13]. Prey capture, our chosen behavioral 
endpoint, is ecologically relevant because it can be related directly to growth and survival 
[7]. 
Many researchers who have examined the effects of neurotransmitter inhibitors on 
aquatic organisms focus on the biochemical responses and neglect to measure behavioral 
responses in a quantitative manner. Fulton and Chambers [14] evaluated behavior 
qualitatively in mosquitofish (Gambusia affinis) reporting normal behavior three weeks 
after exposure to an AChE inhibitor.  They also found that tadpoles (Rana sp.) showed no 
clinical signs associated with neurotoxicity.  Keizer et al. [15] observed symptoms of 
swollen gills and coordination problems in zebrafish (Brachydanio rerio) and guppies 
(Poecilia reticulata) exposed to diazinon, noting that they drifted on their backs at the 
water surface just before death.  Unlike zebrafish, however, the guppies showed these 
symptoms temporarily and then recovered.  A review by Fulton and Key [4] compiled 
laboratory studies in fish and invertebrates in which AChE inhibition and in some cases, 
AChE recovery, was used as a biomarker.  However, these experiments only assessed 
biochemical changes; hence, they could not relate compromised AChE inhibition to 
compromised ecological fitness. These studies underscore the use of AChE activity as a 
biomarker of exposure, but provide little insight into its utility to be used for the 
characterization of effects.   
Although their behavior was significantly impacted, hybrid striped bass tolerated 
over 80% AChE inhibition following a 6-d diazinon exposure. Other researchers have 
reported similar results of AChE inhibition.  Coppage [16] reported brain AChE 
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inhibition by OPs greater than 80% in all fish that survived median lethal exposures, and 
Ferrari et al. [17] reported AChE inhibition values between 77 and 95% following a 96-h 
exposure to multiple OPs.  In addition, bluegill (Lepomis macrocharis) had 95% AChE 
inhibition within 6 h of diazinon exposure, while fathead minnow, goldfish (Carassius 
auratus), and golden shiner (Notemigonus crysoleucas) showed 70, 43, and 40% AChE 
inhibition, respectively, within 18 h of exposure [18].  Goodman et al. [19] also reported 
a 71% AChE inhibition in sheepshead minnow (Cyprinodon variegates) following a 24-h 
exposure to diazinon. 
Contaminants like diazinon can impair feeding behavior by affecting motivation 
to feed, search effectiveness, or ability to capture prey.  Hybrid striped bass tolerated 
more than 66% AChE inhibition before a significant effect on feeding behavior was 
observed, as suggested by the lack of observable, or statistical, behavioral impairments in 
the low treatment group on day 6 (Figure 2.4). We quantified an increased time to capture 
prey and a decreased AChE activity as a result of increased exposure concentrations and 
durations.  Plotting our two endpoints at the end of the exposure against each other, we 
noted a threshold response between biochemistry and behavior at the concentrations 
tested (Figure 4).  
In the present study, we saw a dose-response relationship between AChE 
inhibition and diazinon exposure concentration.  The estimated 6-d EC50 of diazinon on 
AChE activity (mean ± SE) was 15.2 ± 1.1 µg/L.  This value was lower than the 
estimated 6-d EC50 value for feeding behavior (mean ± SE) 50.1 ± 4.0 µg/L (data not 
shown).  Other investigators have reported acute 96-h LC50 values for diazinon for 
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various aquatic species including crayfish (Gammarus fasciatus) 0.2 µg/L [20], Hyallela 
azteca 4.0 µg/L [21], rainbow trout (Oncorhynchus mykiss) 90 µg/L, and bluegill 
(Lepomis macrocharis) 170 µg/L [20].  The differences noted in EC50 values between 
AChE inhibition and behavioral impairments in the present study has also been noted 
when considering AChE activity and swimming stamina in sheepshead minnows [22], 
red drum (Sciaenops ocellatus) [23], mummichog (Fundulus heteroclitus) [23] and 
salmonids [24]. On the other hand, linear correlations between changes in swimming 
speed and AChE activity were noted in rainbow trout [25, 26], and Coho salmon 
(Oncorhynchus kisutch) [27, 28].  
As with the present study, other researchers have found that several factors are 
responsible for the effects of OPs on AChE inhibition and recovery in aquatic organisms 
including the type of OP, exposure duration and concentration, the degree of AChE 
depression, and species exposed [17, 25, 29, 30].  During the recovery period when bass 
were in clean water, there were decreases in time to capture prey as compared to day 6 
for both the medium and high treatments, however only increased times to capture the 
first and second prey for bass in the medium treatment were significant (Figure 2.3).  
When comparing time to capture prey during the recovery period to controls on their 
respective day, only times to capture prey 2 on days 9 and 12 for the medium treatment 
were comparable to controls.  Although bass improved their prey-capturing ability, AChE 
levels were still significantly inhibited (Figure 2.1).  Similarly, Morgan et al. [29] looked 
at recovery times for Atlantic salmon (Salmo salar) exposed to sublethal concentrations 
of fenitrothion and found AChE was still depressed by 34% one week following a 7-d 
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exposure to 213 µg/L, noting that recovery of enzyme activity was related to the degree 
of initial inhibition. Exposure of goldfish (Carassius auratus) to OPs (parathion and 
carbaryl) also showed little increases in cholinesterase activity during a 96-h recovery 
period in clean water.  The tests further revealed that goldfish required at least 35 d of 
depuration to substantially recover cholinesterase activity following the exposure [17].  
Also, AChE activity in eels (Anguilla anguilla) exposed to fenitrothion for 96-h was still 
significantly inhibited 12 d post-exposure as compared to controls [30]. 
Fenitrothion is an OP that has been shown to decrease another aspect of feeding: 
foraging behavior [31].  Researchers found that attack sequences, frequency of ingestion, 
and reaction distance of juvenile Atlantic salmon were all decreased as compared to 
controls. The pesticide-exposed salmon waited until their prey moved closer before 
striking and were more likely to end the sequence before capturing the prey [31].  
Latency to first strike and total food strikes during a fixed time interval were also noted in 
Coho salmon [28]. Although not quantified, similar behavioral abnormalities were 
observed in the present study as well. Many bass in the medium and high treatments 
would strike at their prey unsuccessfully due either to not striking quick enough or not 
being close enough to the prey. After a few failed attempts, bass would no longer strike.  
Other times, bass would follow a minnow around the tank without attempting to strike, or 
swim toward the minnow only to turn around, as if to give up before striking in order to 
conserve energy.  Bass in the highest treatment were virtually uninterested in the 
minnows and were inactive for the most part, even if minnows were within reach with 
minimal energy expenditure required.  
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Prey handling time also increased with increasing diazinon concentration causing 
bass to spend more time and energy consuming the food, thus eating less in a given 
period of time.  Since prey handling depends on coordination of different muscle 
activities that are under the control of the central nervous system, impairment of nerve 
transmission may result in a loss of this coordination [32].  While bass in the medium 
treatment were not as active as the control or low treatments, they were still more active 
than the high treatments.  However, they were noted as having an increased handling time 
as a result of spitting out some captured prey. Bass in the low treatment exhibited no 
signs of behavioral impairment despite having significantly reduced AChE activities at 
all time points measured and would wait anxiously to be fed throughout the duration of 
the experiments.   
Seemingly small impacts on various behaviors can impact both populations and 
community structures.  A decreased efficiency in foraging and prey capture may lead to 
decreased growth and survival, as well as decreased energy available for reproduction.  In 
order to be ecologically fit, fish must maintain essential behaviors.  Dose-response 
relationships may exist for an endpoint at a given level of organization, but the ecological 
relevance at higher levels of organization is often unclear or unknown.  This uncertainty 
is perhaps most obvious, and most difficult to address when attempting to establish links 
between levels of biological organization [33].  
Impaired feeding behaviors as a result of OP exposure could significantly 
decrease the probability of responding to, or capturing prey items.  This could result in a 
decreased growth if the exposure and/or effects were long lasting [31].  However, if 
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behavioral changes were quickly reversed, there may not be significant impacts on higher 
levels of organization.  As with other sublethal toxic effects, it can be difficult to attribute 
ecological relevance to sublethal AChE inhibition [27].  The relationship between AChE 
inhibition and outward signs of intoxiciation can be complex, especially when accounting 
for species and individual variability [17].  Results of the present study demonstrate that 
significant AChE inhibition can occur before behavioral changes are observed, and this 
inhibition can last much longer than the exposure duration. We also noted that the effect 
of diazinon on feeding behavior was recovering to control levels quicker than AChE 
activity.  
Biomarker assays like AChE activity provide clear indications of contaminant 
exposure, yet by itself, does not give a clear indication of how these contaminants affect 
the ecological fitness of an individual.  By evaluating an ecologically relevant behavioral 
endpoint along with AChE activity, it may be possible to better relate this biomarker of 
organophosphate exposure to ecological fitness.  Establishing this relationship would 
help relate sublethal biochemical changes to population-level effects [26], making AChE 
activity a more useful endpoint for use in risk assessments.  
References 
1. Gilliom, RJ, Hamilton PA. 2006. Pesticides in the nations streams and groundwater, 
1992-2001- a summary. USGS Fact Sheet 2006-3028. U.S. Geological Survey, 
Tallahassee, FL.  
 
2. Guilhermino L, Lopes MC, Carvalho AP, Soares AMVM. 1996. Inhibition of 
acetylcholinesterase activity as effect criterion in acute tests with juvenile Daphnia 
magna. Chemosphere 32:727-738. 
 
 48 
3. Pan G, Dutta HM. 1998. The inhibition of brain acetylcholinesterase of juvenile 
largemouth bass Micropterus salmoides by sublethal concentrations of diazinon.  
Environ Res Sect A 79:133-137. 
 
4. Fulton MH, Key PB. 2001. Acetylcholinesterase inhibition in estuarine fish and 
invertebrates as an indicator of organophosphorus insecticide exposure and effects. 
Annual Review. Environ Toxicol Chem 20:37-45. 
 
5. Berndt MP, Hatzell HH. 2001. Does diazinon pose a threat to a neighborhood stream 
in Tallahassee, Florida? USGS Fact Sheet FS-143-00. U.S. Geological Survey, 
Sacramento, CA.  
 
6. Hoffman RS, Capel PD, Larson SJ. 2000. Comparison of pesticides in eight U.S. 
urban streams. Environ Toxicol Chem 19:2249-2258. 
 
7. Weis JS, Smith G, Zhou T, Santiago-Bass C, Weis P. 2001. Effects of contaminants on 
behavior: Biochemical mechanisms and ecological consequences. BioScience 51:209-
217. 
 
8. Weirich, CR, Tomasso, JR, Smith TIJ. 1992. Confinement and transport-induced 
stress in white bass (Morone chrysops) x striped bass (M. saxatilis) hybrids: Effect of 
calcium and salinity. J World Aquacult Soc 23:49-57. 
 
9. Gothreaux C. 2007. Family profile: Moronidae – The temperate basses. Lagniappe 
Fisheries Newsletter 31:3-5.   
 
10. Giddings JM, Biever RC, Annunziato MF, Hosmer AJ. 1996. Effects of diazinon on 
large outdoor pond microcosms. Environ Toxicol Chem 15:618-629. 
 
11. Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. 1961. A new and rapid 
colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-
95. 
 
12. Duquesne S. 2006. Effects of an organophosphate on Daphnia magna at 
suborganismal and organismal levels: Implications for population dynamics. 
Ecotoxicol Environ Saf 65:145-150. 
 
13. Little EE, Archeski RD, Flervo B, Kozlovskaya V. 1990. Behavioral indicators of 
sublethal toxicity in rainbow trout. Arch Environ Contam Toxicol 19:380-385. 
 
14. Fulton MH, Chambers JE. 1985. Inhibition of neurotoxic esterase and 
acetylcholinesterase by organophosphorus compounds in selected ectothermic 
vertebrates. Pestic Biochem Physiol 23:282-288. 
 
 49 
15. Keizer J, D‟Agostion G, Vittozzi L. 1991. The importance of biotransformation in the 
toxicity of xenobiotics to fish. I. Toxicity and bioaccumulation of diazinon in guppy 
(Poecilia reticulata) and zebra fish (Brachydanio rerio).  Aquat Toxicol 21:239-254. 
 
16. Coppage DL. 1972. Organophosphate pesticides: Specific level of brain AChE 
inhibition related to death in sheepshead minnows. Trans Am Fish Soc 101:534-536. 
 
17. Ferrari A, Venturion A, Pechen de D‟Angelo AM. 2004. Time course of brain 
cholinesterase inhibition and recovery following acute and subacute azinphosmethyl, 
parathion and carbaryl exposure in the goldfish (Carassius auratus). Eccotoxicol 
Environ Saf 57:420-425. 
 
18. Weiss CM. 1961. Physiological effect of organic phosphorus insecticides on several 
species of fish. Trans Am Fish Soc 90:143-152. 
 
19. Goodman LR, Hansen DJ, Coppage DL, Moore JC, Matthews E. 1979. Diazinon 
chronic toxicity to, and brain acetylcholinesterase inhibition in, the sheepshead 
minnow, Cyprinodon variegatus. Trans Am Fish Soc 108:479-488. 
 
20. Mayer FL, Ellersieck MR. 1986. Manual of acute toxicity: Interpretation and database 
for 410 chemicals and 66 species of freshwater animals. Resource Publication 160. 
U.S. Department of the Interior, Fish and Wildlife Service, Washington, DC. 
 
21. Collyard SA, Ankley GT, Hoke RA, Goldenstein T. 1994. Influence of age on the 
relative sensitivity of Hyalella azteca to diazinon, alkylphenol ethoxylates, copper, 
cadmium, and zinc. Arch Environ Contam Toxicol 26:110-113. 
 
22. Cripe GM, Goodman, Hansen DJ. 1984. Effect of chronic exposure to EPN and to 
guthion on the critical swimming speed and brain acetylcholinesterase inhibition of 
Cyprinodon variegates. Aquat Toxicol 5:255-266. 
 
23. Van Dolah RF, Maier PP, Fulton MH, Scott GI. 1997. Comparison of azinphosmethyl 
toxicity to juvenile red drum (Sciaenops ocellatus) and the mummichog (Fundulus 
heteroclitus). Environ Toxicol Chem 16:1488-1493. 
 
24. Post G, Leasure R. 1974. Sublethal effect of malathion to three salmonid species.  
Bull Environ Contam Toxicol 12:312-319. 
 
25. Beauvais SL, Jones SB, Parris JT, Brewer SK, Little EE. 2001. Cholinergic and 
behavioral neurotoxicity of carbaryl and cadmium to larval rainbow trout 
(Oncorhynchus mykiss). Ecotoxicol Environ Saf 49:84-90. 
 
 
 50 
26. Beauvais SL, Jones SB, Brewer SK, Little EE. 2000. Physiological measures of 
neurotoxicity of diazinon and malathion to larval rainbow trout (Oncorhynchus 
mykiss) and their correlation with behavioral measures. Environ Toxicol Chem 
19:1875-1880. 
 
27. Tierney K, Casselman M, Takeda S, Farrell T, Kennedy C. 2007. The relationship 
between cholinesterase inhibition and two types of swimming performance in 
chlorpyrifos-exposed coho salmon (Oncorhynchus kisutch). Environ Toxicol Chem 
26:998-1004. 
 
28. Sandahl JF, Baldwin DH, Jenkins JJ, Scholtz NL. 2005. Comparative thresholds for 
acetylcholinesterase inhibition and behavioral impairment in coho salmon exposed to 
chlorpyrifos. Environ Toxicol Chem 24:136-145. 
 
29. Morgan MJ, Fancey LL, Kiceniuk JW. 1990. Response and recovery of brain AChE 
activity in atlantic salmon exposed to fenitrothion. Can J Fish Aquat Sci 47:1652-
1654. 
 
30. Sancho E, Ferrando MD, Andreu E. 1997. Response and recovery of brain 
acetylcholinesterase activity in the European eel, Anguilla anguilla, exposed to 
fenitrothion. Ecotoxicol Environ Saf 38:205-209. 
 
31. Morgan MJ, Kiceniuk JW. 1990. Effect of fenitrothion on the foraging behavior of 
juvenile Atlantic salmon. Environ Toxicol Chem 9:489-495. 
 
32. Pavlov DD, Chuiko GM, Gerassimov YV, Tonkopiy VD. 1992. Feeding behavior and 
brain acetylcholinesterase activity in bream (Abarmis brama L.) as affected by 
DDVP, an organophosphorus insecticide. Comp Biochem Physiol C 103:563-568. 
 
33. Sibley PK, Chappel MJ, George TK, Solomon KR, Liber K. 2000. Integrating effects 
of stressors across levels of biological organization: Examples using 
organophosphorous insecticide mixtures in field-level exposures. J Aquat Ecosyst 
Stress Recovery 7:117-130. 
 
 51 
 
 
 
Figure 2.1. Brain acetylcholinesterase activity (AChE)  (mean ± SE) in hybrid striped 
bass during a 6-day waterborne exposure to diazinon, followed by a 6-day recovery 
period. Means with the same letter are not statistically different from each other. Vertical 
line at day 6 separates exposure and recovery time points.  
 
 
 
 
 52 
 
 
 
Figure 2.2. Day 6 acetylcholinestrease (AChE) activity (mean ± SE) as a function of 
measured diazinon concentration (mean ± SE).  The estimated 6-day EC50 was 15.2 ± 
1.1 µg/L. Error bars indicate 95% confidence intervals.  
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Figure 2.3. Time (mean ± SE) it took hybrid striped bass to capture the first (A), 
second (B) and third (C) prey fish during a 6-day diazinon exposure followed by a 6-
day recovery period. Means with the same letter are not statistically different from 
each other. Vertical line at day 6 separates exposure and recovery time points. 
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Figure 2.4. Day 6 time to eat prey 1 and prey 2 (mean ± SE) as a function of brain 
acetylcholinestrease activity (AChE) (mean ± SE) in hybrid striped bass. 
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CHAPTER 3: BEHAVIORAL AND BIOCHEMICAL RESPONSES OF HYBRID  
STRIPED BASS DURING AND AFTER FLUOXETINE EXPOSURE  
Abstract 
Environmental contaminants, including pharmaceuticals, can alter behavior and 
possibly impact population and community structures.  One important behavior that could 
be impacted is the ability to capture prey.  We hypothesized that sublethal fluoxetine 
exposure may lead to feeding behavior abnormalities in hybrid striped bass (Morone 
saxatilis x M. chrysops).  Fluoxetine is an antidepressant that acts as a selective serotonin 
reuptake inhibitor (SSRI).  A change in serotonin levels affects multiple behaviors 
including feeding, which is an important aspect in ecological fitness. This research 
characterized the impact of sublethal fluoxetine exposures on the ability of hybrid striped 
bass to capture fathead minnows (Pimephales promelas). Bass were exposed to 
fluoxetine (0.0 µg/l, 23.2 + 6.6 µg/l, 51.4 + 10.9 µg/l and 100.9 + 18.6 µg/l,) for six days, 
followed by a six-day recovery period in clean water. Brain serotonin activity and the 
ability of bass to capture prey were measured every third day.  Exposed fish exhibited a 
concentration- and duration- dependent decrease in ability to capture prey.  Increased 
time to capture prey also correlated with decreases in brain serotonin activity.  Serotonin 
activity also decreased in an exposure time- and concentration-dependent manner, 
maximally inhibited 23.7%, 28.0%, and 49.1% of control in the low, medium, and high 
treatments, respectively.  Serotonin levels in exposed fish did not recover to control 
levels during the six-day recovery period.  These results suggest that sublethal exposure 
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to fluoxetine decreases the ability of hybrid striped bass to capture prey and that serotonin 
can be used as a biomarker of exposure and effect. 
Introduction 
Many pollutants adversely affect normal endocrine functions, and unfortunately, 
these chemicals are ubiquitous in the environment [1].  The central nervous system is a 
target of endocrine-disruptors, so social behaviors under hormonal control such as 
aggression, dominance, motivation, and activity are often directly impacted by exposure 
to these contaminants [1].  Behavior is a major link between the organism and its 
environment [2].  It is both a result and determinant of molecular, physiological, and 
ecological aspects of toxicology; therefore, it provides insight into various levels of 
biological organization [3].  Behavioral responses also reflect an organism‟s ecological 
fitness and its abilities to avoid predators, select prey items, and reproduce [2].  
Alterations in any of these behaviors, coupled with changes in physiology may alter 
population stability [3]. 
Fluoxetine (Prozac™) is an antidepressant that acts as a selective serotonin 
reuptake inhibitor (SSRI). Serotonin functions as a neurotransmitter to regulate a wide 
range of behaviors including feeding activity, aggressive interactions, sexual behavior, 
and establishment of social hierarchies [4, 5].  SSRIs, like fluoxetine, act by inhibiting the 
reuptake of serotonin from the synaptic cleft, and increasing extracellular serotonin 
levels.  They have been effective in improving mood levels and decreasing appetite and 
aggression.   Therefore, SSRIs are commonly prescribed for depression, compulsive 
behaviors, and personality disorders [6].  
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Fluoxetine, like most drugs, was developed with the intent of altering 
biochemistry and having specific pharmacological and physiological functions.  Many 
drugs are polar, nonvolatile, and nonbiodegradable [7, 8] so they tend to escape 
sedimentation and biological treatment in wastewater treatment plants [5, 7].  They are 
persistent in order to reach the target site before becoming inactive, but this also increases 
the possibility of bioaccumulation in aquatic or terrestrial organisms [8]. The high 
frequency of use and continual output of drugs from wastewater treatment plants and 
other sources simulates episodic or continuous exposures, rather than acute exposures.  
Consequently, low levels of fluoxetine (and other pharmaceuticals and personal-care 
products) have been found in treated sewage effluent, sediment, surface waters, and city 
water supplies [9].  Although present in the environment at concentration in the ng/l 
range[10], numerous aquatic species including fish have been found to contain detectable 
amounts of fluoxetine [11].   
Fluoxetine exposure has also been shown to affect various aspects of behavior in 
aquatic organisms.  Studies have shown that exposure to antidepressants can trigger 
premature spawning in fingernail clams (Sphaerium striatinum) [12], and zebra mussels 
(Dreissena polymorpha) [13], decreased fecundity in Cerodaphnia dubia [14], decreased 
growth in algae (Pseudokirchneriella subcapitata) [14] and decreased growth and feeding 
rates in fathead minnows (Pimephales promelas) [15].   
Assessing the human risk of pharmaceuticals in waters is a high priority; 
however, the impacts of these drugs on aquatic organisms and communities are also 
important [7, 9].  A better understanding of toxicological effects of contaminants can be 
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achieved by integrating behavioral indicators of toxicology with those of other levels [3].  
The gol of this study was to (1) determine the effects of waterborne fluoxetine on the 
feeding behavior of hybrid striped bass (Morone saxatilis x M. chrysops); and (2) 
correlate these changes with changes in brain serotonin levels at various time points of 
exposure and recovery.  Fish are an excellent model for studying effects of environmental 
pollutants because many ecologically relevant fish behaviors are easily observed and 
quantified in controlled settings [3].  Feeding behavior was chosen because our previous 
research demonstrated that changes in this behavior were quantitatively related to 
neurotoxin exposure and neurotransmitter concentrations [16].  Bass were monitored 
during a six-day exposure period followed by an additional six days in clean water to 
observe any latent effects of exposure that may not otherwise be identified at the end of 
the exposure period.  This also allowed us to look at the sensitivity of both biochemical 
and behavioral endpoints and how these endpoints changed during recovery. Fluoxetine 
concentrations were tested at levels greater that those found in the environment in order 
to more clearly quantify potential impacts of fluoxetine on fish brain monoamines and 
feeding behavior. 
Materials and Methods 
Test chemicals 
  Fluoxetine hydrochloride, was generously donated by Fermion  (Finland).  
Perchloric acid, aqueous (0.1 N), was purchased from VWR (USA).  Methanol, acetone, 
triethylamine, acetolnitrile, glacial acetic acid, monochloro-acetic acid, and 
tetrahydrofuran were purchased from Fisher Scientific (USA).  Sodium hydroxide, 
 59 
sodium octyl sulfate, ethylenediaminetetraacetic acid (EDTA) disodium salt, 5-
hydroxyindole-3-acetic acid (5-HIAA), and serotonin creatinine sulfate monohydrate (5-
HT) were purchased from Sigma-Aldrich (USA).  
Fish 
  Hybrid striped bass (Morone saxatilis x M. chrysops) were obtained from 
Southland Fisheries near Columbia, SC.  Fish were housed in 450 L circular flow-
through holding tanks at Clemson University‟s Institute of Environmental Toxicology 
and fed a pellet food (Zeigler Brothers, Gardners, PA) daily.  Larval fathead minnows 
(Pimephales promelas) were obtained from a culture maintained at Clemson University 
Institute of Environmental Toxicology and reared until they were the appropriate size (~4 
cm) to be used in the tests. 
Experimental design 
Hybrid striped bass were exposed to fluoxetine for 6 days under static conditions, 
followed by a 6-day recovery period (water flow was turned back on at a rate of 0.23 
liters per minute), for a total of 12 days.  Fish were fed on days 0, 3, 6, 9, and 12 and 
feeding behavior was quantified. Fish brains were extracted for monoamine analysis at 
the end of each test (see below).  Hence, four tests conducted for 3, 6, 9, or 12 days in 
which bass were fed every third day and brains were harvested at the end of each test. 
Hybrid striped bass (average weight: 163.4 + 27.4 g; average length: 21.5 + 1.2 
cm) were randomly placed individually into twenty-four 80-L aquaria operated under 
flow-through conditions (0.23 liters per minute).  Bass were allowed to acclimate for 
seven days prior to test initiation.  A nearby lake, Lake Hartwell (SC, USA), was the 
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source of test waters (pH = 6.28 + 0.17, Hardness 24 mg/L as CaCO3, Alkalinity 10 mg/L 
as CaCO3).  Water was pumped through a multi-resin filtration system (Water and Power 
Technologies, Columbia, SC) to remove suspended solids prior to entering experimental 
tanks. Water temperature was controlled using a mixing valve (M & M Control Services, 
Grayslake, IL) that regulated a mixture of ambient and chilled water (ambient water 
circulated through an in-line chiller) or heated water (ambient water circulated through an 
in-line heater) depending on the ambient conditions (summer or winter months, 
respectively) to facilitate achieving a desired temperature of about 25C (23.8 +1.07 C).   
 Bass were fed four fathead minnows every third day during the acclimation 
period.  This feeding regime ensured the bass were hungry and were accustomed to 
eating live minnows. Bass were fed on days 1, 4, and 7 of the acclimation period so that 
the last day of acclimating coincided with day 0 of the fluoxetine exposure.  Feeding 
behavior (time to capture prey) of hybrid striped bass was quantified every third day 
during the test as well. 
Prior to feeding, air stones were removed from each tank at each time point, and 
water flow was turned off during the recovery period. Four fathead minnows were 
dropped into an exposure tank and the time to eat each prey was recorded. Minnows used 
in the tests were visually estimated to be 4 cm.  Minnows of similar size were pre-
selected prior to feeding to ensure that no extremely large or small minnows were used to 
skew appetite satiation. Minnows were then randomly selected and fed to bass without 
regard to treatment.  Bass that did not eat all four minnows prior to exposure initiation 
were eliminated from the test to reduce any confounding factors. Bass were observed 
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until all minnows were consumed or for a maximum of 25 minutes.  Any uneaten 
minnows after 25 minutes were removed from the tank.  For statistical purposes, uneaten 
minnow was assigned a value of 1500 seconds (25 minutes).  
Fluoxetine exposure 
Treatments of four nominal fluoxetine concentrations (0, 35, 75, 150 µg/l) were 
conducted with five replicate tanks per treatment.  At test initiation, water flow was 
turned off and an appropriate quantity of fluoxetine stock dissolved in methanol was 
added to each aquarium.  One concentrated stock solution of fluoxetine was prepared for 
all tanks in order to reduce tank-to-tank variability within treatments.   Final methanol 
volume did not exceed 1,000 µl in 80 L of water.  The toxicity of methanol to fish has 
been shown to be greater than 15, 000 mg/l [17], and the ASTM standard guide for 
conducting early life-stage toxicity tests with fishes  (ASTM E1241-92) allows methanol 
as a carrier solvent at concentrations not to exceed 0.1 mg/l.  In our experimental setup, 
methanol concentrations did not exceed 0.01 mg/l.   
Test waters were allowed to equilibrate for 1-2 hours prior to taking 250 ml water 
samples for fluoxetine analysis.  These water samples were acidified to pH ~2.5 before 
being filtered through 6 ml C18 solid phase extraction columns (PrepSep™, Fisher 
Scientific, USA) that were preconditioned with 6 ml acetone, 6 ml methanol, and 6 ml 
deionized water.  Extraction columns were dried for at least 30 minutes at room 
temperature on a vacuum manifold (JT Baker, Philipsburg, NJ) before eluting fluoxetine 
with methanol/1% acetic acid.  Control, low, and medium fluoxetine treatment samples 
were diluted to 5 ml in methanol/1% acetic acid, while the high concentration samples 
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were diluted to 10 ml.  Samples were stored at -20C until analyzed by HPLC-
fluorescence.    
 Fluoxetine half-life was previously determined to be approximately 72 hours 
under test conditions.  Therefore, waters were spiked with half original fluoxetine 
concentration on day 3 of exposure period.  Water samples for fluoxetine analysis were 
taken on day 0, day 3 after spiking waters, and day 6 at the end of the exposure.  
Fluoxetine analysis 
Aqueous fluoxetine concentrations were determined on a Waters 1525 Breeze 
HPLC pump with a Waters 717 Plus autosampler and Waters 2475 multi-wavelength 
fluorescence detector (Waters, Milford, MA).  Mobile phase was composed of 350 ml 
acetonitrile, 650 ml water, and 4 ml triethylamine.  Mobile phase was adjusted to pH 4 
with glacial acetic acid.  Flow rate was set at 1 ml/min for a 40 µl injection, and the 
Alltech Prevail C18 column (150 mm, 4.66 I.D.) was set at 30C.  Fluorescence detector 
was set at 230 nm Ex/ 310 nm Em. Run time per sample was approximately 18 minutes. 
Brain tissue preparation 
Bass were euthanized in buffered MS-222 and brains were quickly removed and 
put on dry ice prior for storage at -80C until processed.  Brains were thawed, 
homogenized for 20 seconds by ultrasonic disruption in 1.0 ml 0.1N perchloric acid 
containing 0.2 pg/µl DHBA as the internal standard. Homogenates were then centrifuged 
at 21,000 rpm and 4C for 20 minutes to remove cellular debris.  Supernatant was stored 
at -80C until used for bioassays. 
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Protein assay  
Protein concentrations were determined using a BCA™ Protein Assay Kit (Pierce, 
Rockford, IL, USA).  Brain homogenates were diluted 1:4 in 0.1N perchloric acid prior to 
running the assay. Brain monoamine levels were normalized using protein 
concentrations. 
Monoamine analysis 
Brain samples were analyzed via HPLC with an electrochemical detector with 
methods modified from Lin and Pivorun [22].  The chromatographic system consisted of 
a Bioanalytical System LC-4C amperometric detector, PM-80 pump, and a C18 reverse-
phase column (ODS-2 Hypersil 250 mm x 4.6 mm).  Aliquots of 30 µl were injected into 
the sample loop (20 µl) of a rotary injection valve.  Flow rate was 1.0 ml/min, with the 
electrode potential maintained at +0.8 volts versus Ag/AgCl.  Mixed monoamine 
standards was prepared with NE, DA, 5-HIAA, and 5-HT ranging from 150 pg/µg to 10 
pg/µg in 0.1N perchloric acid.  Each standard also contained 50 pg/µl DHBA as the 
internal standard. Each sample run took 35 minutes. 
The mobile phase consisted of 14.2 g monochloroacetic acid, 4.7 g sodium 
hydroxide, 10.0 mg disodium EDTA, 150 mg sodium octyl sulfate dissolved in 967 mL 
Milli-Q water with 15 ml of methanol and 18 ml of tetrahydrofuran.  The mobile phase 
was filtered through a 0.45 µm white nylon Millipore filter before adding methanol and 
tetrahydrofuran.  The mobile phase was degassed via sonication prior to use. 
 
 
 64 
Data analysis 
Data for time to capture prey was analyzed using Statistical Analysis Software 9.1 
(SAS; Cary, NC, USA) with two-factor ANOVA (analysis of variance) models utilizing 
treatment and day as the independent variables.  Since the time to capture prey data were 
non-normally distributed with non-homogeneous variances, PROC GLIMMIX (General 
Linear Model for Mixture Distributions), an analyses matrix that accounts for non-
normality and non-homogeneous variances, was used to perform multiple pair-wise 
comparisons.  The LSMEANS statement in PROC GLIMMIX was used to differentiate 
statistical differences across and within treatment, day, and treatment-by-day interactions. 
Monoamine analyses were also performed using two-factor ANOVA models 
utilizing treatment and day as the independent variables.  Although monoamine data were 
normally distributed with homogeneous variance, PROC GLIMMIX with LSMEANS 
statement was executed to differentiate statistical differences among and within the 
independent variables (treatment, day, and the treatment-by-day interaction terms) rather 
than separate LSMEANS statements within PROC GLM (ANOVA analyses) by day or 
treatment.  An  = 0.05 was used with both time to capture prey and monoamine analyses 
when examining statistical significance of factors using PROC ANOVA and PROC 
GLIMMIX. 
Results 
Fluoxetine concentrations  
Measured fluoxetine concentrations were approximately 67% of the nominal 
concentrations most likely due to photolysis, and some sorption to debris in aquaria.  
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Extraction efficiencies were 90-100% (data not shown).  Measured concentrations (mean 
± standard deviation) throughout the exposure period for the low (35 µg/l), medium (75 
µg/l) and high (150 µg/l) treatments were 23.2 ± 6.6, 51.4 ± 10.9, and 100.9 ± 18.6 µg/l, 
respectively.   
5-HT levels  
Brain serotonin levels in low, medium, and high fluoxetine treatments decreased 
as exposure time increased (Table 1), with maximum depression occurring on day 9 (3 
days post exposure).  Serotonin levels were depressed 23.7, 28.0, and 49.1% by day 9 in 
the low, medium, and high treatments, respectively.  The low fluoxetine treatment was 
not significantly different from controls until 3 and 6 days post exposure on days 9 and 
12, respectively.  Bass in the medium and high treatment groups exhibited significantly 
depressed serotonin levels at all time points past day 0.  Serotonin levels in all treatments 
began to increase during the recovery period between days 9 and 12.  Serotonin in the 
high treatment decreased significantly between days 6 and 9 with a corresponding 
increase during the recovery period between days 9 and 12. None of the fluoxetine 
treated bass recovered completely to control serotonin levels.  
To determine the 6-d EC50 for serotonin depression, serotonin levels and 
fluoxetine concentrations were plotted and 50% effect concentrations were calculated 
using the polynomial equation. The estimated 6-d EC50 was 24.0 µg/L (Figure 3.1).  
5-HIAA Levels 
 5-HIAA levels were significantly depressed as a result of fluoxetine exposure in 
all treatment groups (Table 1).  On days 3 and 9 (3 days post exposure), all fluoxetine 
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treatments were significantly different from controls, but not from each other.  On day 6, 
all treatments were significantly different from controls, and the high treatment group 
was significantly lower than low and medium treatments.  On day 12 however (6 days 
post exposure), while all treatments were significantly different from controls, 5-HIAA 
levels in the high treatment increased dramatically so that they were significantly greater 
than low and medium treatment groups. 
5-HIAA:5-HT ratio 
 Both serotonin and 5-hydroxyindoleacetic acid were depressed as a result of 
fluoxetine exposure.  Further, the ratio of 5-HIAA:5-HT was significantly lower in all 
treatment groups as compared to controls on day 3 (Table 1).  On day 6, low and high 
treatment groups were significantly different from controls, yet they were not 
significantly different from the medium treatment.  On day 9, only the high treatment 
group was significantly different than controls, due to both continual declines in 5-HT 
and spikes in 5-HIAA levels.  The low fluoxetine group was the only treatment 
significantly lower than controls at the end of the test on day 12. 
Behavior Data: Exposure/Recovery Effects 
 On day 0, behavior data was recorded prior to initial fluoxetine exposure.  
There were no significant differences among treatment groups.  In the low treatment 
group, there was a concentration- and duration-dependent effect of fluoxetine on time to 
capture prey (Figure 3.2).  Time to eat increased significantly between capturing the first 
and second prey fish in the low treatment.  By day 12, the sixth day of recovery, time to 
capture prey decreased to levels comparable to control levels.  In the medium treatment, 
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time to capture prey was significantly different from controls at all time points, with the 
exception of time to capture prey one on day 12 (Figure 3.2a).  Time to capture prey 
decreased as recovery time increased.  In the high treatment, time to capture prey 
increased through day 12 for the first prey fish, and through day 9 for the second and 
third prey fish (Figures 3.2b and 3.2c).  See Appendix Table A-2 for mean ± SE values 
for time to capture prey for each treatment and day. 
Discussion 
SSRIs inhibit 5-HT transporters within minutes, yet it is only after a few weeks of 
treatment that they exert their full antidepressant effect [19-21].  Therefore, it is the 
adaptive changes of the 5-HT-containing neurons and receptors that underlie their 
therapeutic effect, not just the inhibition of 5-HT transporters [19].  Serotonin-containing 
neurons are endowed with somatodendritic 5-HT1A autoreceptors that exert a negative 
feedback influence on their firing activity [19].  During prolonged SSRI treatment the 5-
HT1A autoreceptors may become desensitized, thus explaining the recovery of normal 
firing activity of 5-HT-containing neurons [19, 22].  Chronic treatment with SSRIs cause 
antidepressant effects (a rise in 5-HT concentrations in the terminal region), but acute 
treatment may not [23].  For example, a two-day treatment with SSRIs decreased the 
firing activity of 5-HT-containing neurons, but a two-week treatment resulted in neurons 
progressively regaining their normal firing activity [19].  
The results from our study may suggest that 5-HT1A autoreceptors were activated, 
resulting in a decreased release of serotonin in hybrid striped bass following a 6-day 
fluoxetine exposure. Serotonin levels in fluoxetine treated bass were decreasing with 
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increasing exposure duration to fluoxetine (Table 1). It could be hypothesized that if bass 
in our study were exposed for longer durations, serotonin levels as well as time to capture 
prey would recover to control levels as a result of the delayed enhancement of 5-HT-
mediated transmission following prolonged fluoxetine treatments. This underscores the 
need for chronic studies since freshwater organisms are likely to be exposed to low levels 
of fluoxetine over long periods of time.  
Following the release of serotonin into the synapse, it continues to stimulate pre-
and post-synaptic receptors until it is either taken back up by the presynaptic neuron for 
reuse, or it is metabolized to 5-hydroxyindoleacetic acid (5-HIAA) by monoamine 
oxidase [24] in the presynaptic neuron or synaptic cleft.  Serotonin turnover is often 
reported as the ratio of 5-HIAA:5-HT.  While it is possible that treatment with SSRIs can 
increase the ratio due to the decrease in the reuptake of serotonin, and thus metabolism by 
monoamine oxidases, it has also been shown that stress could increase the 5-HIAA:5-HT 
ratio, due to increased 5-HIAA levels [25].  However, in the present study, both 5-HIAA 
and 5-HT levels were reduced in the whole brains of hybrid striped bass exposed to 
fluoxetine.  Betta splendens also exhibited declines in 5-HT in the forebrain and 5-HIAA 
in the forebrain and hindbrain following 14 daily i.p. injections of fluoxetine (4.3 mmol), 
resulting in a significant reduction in serotonergic activity (5-HIAA:5-HT) in the 
hindbrain [26].  Yet there were no changes in their aggression. In the present study, 5-HT 
levels decreased in a dose-dependent manner (Figure 3.1) and 5-HIAA levels decreased 
with no clear dose-dependent relationship in hybrid striped bass.  As a result, we saw a 
decrease in the 5-HIAA:5-HT ratio during fluoxetine exposures. 
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Although serotonin levels continued to decrease three days into the recovery 
period (day 9), 5-HIAA levels in all treatments increased between days 6 and 9 (Table 1), 
with 5-HIAA levels increasing significantly in the high treatment.  This resulted in a 
spike in the 5-HIAA : 5-HT ratio in bass in the high treatment, rather than a gradual 
increase in the ratio (Table 1).  By day 12, the sixth day of recovery, 5-HIAA levels in 
the high treatment increased to levels that were significantly greater than the low and 
medium treatment groups.  However recovery of 5-HIAA to control levels had not 
occurred by day 12 in any treatment.  
It has also been shown that food deprivation may increase brain 5-HIAA levels in 
mammals due to an increased synthesis and metabolism of serotonin [27]. It may be 
possible that high exposures to fluoxetine, which is effective in decreasing appetite, may 
have contributed to the sharp increase in 5-HIAA levels seen in bass in the high treatment 
group between days 6 and 9.  In the present study, bass in the high fluoxetine treatment 
took significantly longer to eat the first and second prey fish as compared to the other 
treatment groups.  They did not eat as many, if any, minnows as compared to the other 
treatment groups during the exposure and recovery periods.  The decreased time to eat 
exhibited by fish in the low and medium treatments was not seen in the high treatment 
during the recovery period. (Figures 3.2a and 3.2b).  This reduction in food consumption 
is consistent with reports of suppressed appetite with SSRI treatment [28, 29].  However, 
fluoxetine elicits this anorexic effect as a result of increased levels of extracellular 5-HT 
[24, 29, 30], not a decrease in 5-HT levels as seen in our study.  We saw a strong 
negative relationship between serotonin levels and time to capture prey (Figure 3.3).   
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One explanation for the reduced serotonin levels into the recovery period could be 
that a reduced energy intake (i.e. reduced feeding) can also significantly reduce 5-HT 
concentrations in the brain [24].  Bass in all treatments had lower serotonin levels into the 
recovery period, but bass in the high treatment showed significantly lower serotonin on 
day 9 (day 3 of recovery) than the other treatments.  This could be the result of the bass 
not eating nearly as many minnow, thus further reducing energy intake.  
Another suggestion for the continued decrease in serotonin levels three days into 
the recovery period (day 9) could be latent effects of fluoxetine.  The half-live of 
fluoxetine has been reported as one to four days in mammals and we should be able to 
apply this concept to fish [31] since fish have been shown to have high levels of sequence 
identity for serotonin transporter protein and 5-HT1A receptors genes when compared to 
humans, rodent, and bovine  [32, 33]. 
Supporting the results of the present study, juvenile Pimephales promelas (1-250 
µg/l) feeding rates were reduced in a dose dependent manner following a 7-day 
waterborne fluoxetine exposure.  On the other hand, grazing rates of Daphnia magna 
increased with fluoxetine concentrations following a 21-day chronic toxicity test (10-
1000 µg/l), though not significantly [15].  This may be the result of desensitized 5-HT1A 
autoreceptors following an extended exposure duration as discussed earlier.  
Unfortunately, they did not measure brain serotonin levels to correlate these changes in 
behavior with biochemical changes.  Due to the critical role of serotonin, and the 
potential for SSRIs to alter an organism‟s ecological fitness, linking measured 
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biochemical levels with behavioral changes is important when assessing the impacts of 
pharmaceuticals on aquatic organisms. 
In vertebrates, chronically increased serotonin levels can decrease aggression, 
resulting in subordinate males having higher serotonergic activity  [26, 34].  Clements 
and Schreck [35] noted a decrease in locomotor activity in Chinook salmon 
(Oncorhynchus tshawytscha) following daily 2.5 mg/kg i.p. fluoxetine injections for 10 
days as compared to the saline control.  Male bluehead wrasse (Thalassoma bifasciatum) 
injected with fluoxetine daily for 14 days (6 µg/g/day) also exhibited significantly 
decreased aggression [36].  Even though changes in serotonin levels were not measured, 
Semsar et al. [36] implied that serotonin levels increased in a dose-dependent manner due 
to the mode of action of fluoxetine and the behaviors observed. However, results from 
our study contradict this belief since we saw decreased feeding rates accompanied by 
decreased whole-brain serotonin levels. 
In the present study, bass exposed to high fluoxetine concentrations were 
observed maintaining their position at the top of the water surface rather than the bottom 
of the tank like control bass, sometimes with their dorsal fin out of the water.  They were 
also noted to maintain a vertical position in the aquaria; these behaviors persisted 
throughout both the exposure and recovery periods.  Mosquitofish (Gambusia affinis) 
exposed to fluoxetine have also shown abnormal behavior compared to unexposed fish 
including changing position in the water column so that they were closely associated with 
the water surface and tended to lay on their sides with little or no swimming movements 
[37].  Although concentrations used in the present study are above those found in the 
 72 
environment (typically less than 0.1 µg/l [10]), effects of this nature could have 
detrimental effects on an organism in the presence of predators. 
Behavioral data are useful as predictive indices of population and community-
level effects because disruption of essential functions such as predator-prey relationships 
can become ecologically apparent through population changes when enough individuals 
are affected [2].  Feeding behavior is crucial for the development, fitness, and long-term 
viabiliy of an organism and is clearly relevant to the assessment of environmental 
stressors such as sublethal contaminant exposure [2].  Serotonin has been shown to have 
a crucial role in many aspects of behavior and biochemical processes.  Laboratory studies 
have shown contradictory results in different species [38]. However, although species 
sensitivity may be a major contributing factor, concentration, duration, and route of 
exposure may be just as important.  In the present study, there was a dose-dependent 
response between serotonin levels and fluoxetine concentrations (Figure 3.1) as well as a 
strong linear relationship between serotonin levels and feeding behavior in bass (Figure 
3.3).  This linear response was contrary to the non-linear relationship between feeding 
behavior and brain acetylcholinestrease (AChE) activity in hybrid striped bass exposed to 
diazinon [16].  AChE activity could be inhibited at concentrations significantly lower 
than those needed to change behavior.  This suggests that there may be excess AChE 
activity and that bass feeding behavior is not affected until enzyme activity is inhibited by 
greater than 60%.  Results of the present research demonstrate that behavior changes as 
soon as serotonin levels decrease.  These results underscore the use of serotonin as a 
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biomarker of fluoxetine exposure as well as a biomarker of effect that signals 
compromised ecological fitness.  
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Table 3.1: Serotonin (5-HT) and 5-hydroxyindoleaceteic acid (5-HIAA) levels (mean ± 
SE) in hybrid striped bass brains (pg/µg protein), and 5-HIAA:5-HT ratios following a 6-
day fluoxetine exposure followed by a 6-day recovery period.  a through i denotes 
significant differences among treatment and day for each. (On previous page) 
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Figure 3.1. Day 6 serotonin (5-HT) levels as a function fluoxetine concentration.  The 
estimated 6-day EC50 was 24.0 µg/l. 
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Figure 3.2. Time (mean ± SE) it took hybrid striped bass to capture the first (A) first, (B) 
second, and (C) third prey fish during as 6-day fluoxetine exposure followed by a 6-day 
recovery period. The vertical line at day 6 signifies the end of the exposure period and 
beginning of the recovery period. Means with the same letter are not significantly 
different from each other. 
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Figure 3.3. Day 6 time to eat prey 1 and prey 2 as a function of brain serotonin levels in 
hybrid striped bass.  
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CHAPTER 4: LONG-TERM FLUOXETINE EXPOSURE: BEHAVIORAL AND  
BIOCHEMICAL EFFECTS  
Abstract 
Research conducted has shown that pharmaceuticals present in aquatic 
environments can alter behavior in aquatic organisms.  Previous work in our lab has 
shown that short-term exposure to fluoxetine, a selective serotonin reuptake inhibitor, 
alters serotonin levels and feeding behavior in hybrid striped bass (Morone saxatilis x M. 
chrysops).  The current study characterized effects of long-term fluoxetine exposure on 
hybrid striped bass.   Bass were exposed to fluoxetine (0, 0.1, 1.0, and 10 µg/L) for 27 
days.  Time to capture prey, Pimephales promelas, was measured every third day and 
brain serotonin levels were measured on days 0, 6, 12, 21, and 27. 5-Hydroxyindoleacetic 
acid (5-HIAA), norepinehrine, and dopamine levels were also monitored at these times.  
There were no clear concentration- or exposure duration-dependent changes in feeding 
behavior, norepinephrine levels, or dopamine levels.  While there was no clear dose-
response in serotonin levels, there was a significant decrease in 5-HIAA levels in bass in 
the 10 µg/L fluoxetine treatment as compared to controls.  These results suggest that 
environmentally relevant fluoxetine concentrations do not significantly affect serotonin 
levels or feeding behavior in hybrid striped bass. 
Introduction 
 A diverse number of pharmaceuticals are produced and used in large quantities 
around the world both for human and animal consumption (Bound and Voluvoulis, 
2004). They are absorbed by an organism after intake and are subject to metabolic 
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reactions, but metabolism and elimination rates largely depend on the individual, the 
drug, and the dose.  Sometimes, large proportions (up to 90%) of these drugs can leave 
the body unmetabolized and make their way into wastewater treatment plants (WWTPs) 
[1, 2]. Many of these drugs are polar, escape sedimentation, and resist biological 
treatment in WWTPs [3].  Recent studies have found that the incomplete removal of 
these compounds during the treatment process results in the discharge of these drugs into 
the aquatic environment [3, 4].  
The US Food and Drug Administration (FDA) has been regulating 
pharmaceuticals in the environment in the USA since 1977 through the environmental 
review process for New Drug Applications that are submitted. When a new drug is 
proposed for market, FDA requires risk assessments to estimate concentrations that could 
be found in the environment as a result of excretion.  If this concentration is less than 1 
µg/l, the drug is assumed to pose acceptable risk [5, 6].  As a result, the FDA has never 
turned down a proposed new drug based on estimated environmental concentrations, but 
no actual testing is conducted after a drug is marketed to see if the estimation was correct 
[6]. Nevertheless, some small streams are dominated by WWTP effluent and have been 
found to contain pharmaceutical concentrations exceeding 1 µg/l [7].  Unfortunately, US 
Environmental Protection Agency water quality criteria do not exist for steroid or non-
steroid pharmaceuticals [5]. 
 One class of pharmaceuticals found in the environment is selective serotonin 
reuptake inhibitors (SSRIs). SSRIs are one of the most prescribed pharmaceuticals in the 
US (rxlist.com, 2008). The first SSRI, fluoxetine (Prozac™), gained national attention in 
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1990 when it was referred to, in Newsweek, as „a breakthrough drug in the treatment of 
depression: a once-a-day medication with acceptable side effects and relatively safe 
cardiac effects‟ [8].  Fluoxetine is also prescribed commonly to treat obsessive-
compulsive and eating disorders [8].  As an SSRI, fluoxetine blocks serotonin reuptake 
transporters that return released serotonin back to the presynaptic terminal, in order to 
elevate serotonin levels and increase serotonin neurotransmission [9, 10]. 
Serotonin is likely one of the most potent and ubiquitous neuromodulators in 
plants, invertebrates, and vertebrates [11] playing a role in many essential aspects of life 
including eating, sleeping, sexual behavior, and mood [8].  Since serotonin regulates so 
many critical functions, it is possible that exposure to SSRIs could disrupt a number of 
behavioral functions in non-target species, including appetite [12].  Fluoxetine has been 
shown to suppress appetite in laboratory animals, and reduce meal size without affecting 
eating frequency [8]. 
While only 10% of excreted fluoxetine is as the unmetabolized parent compound 
[13], the main metabolite, norfluoxetine, has a similar mode of action as the parent 
compound.  While environmental concentrations of norfluoxetine have not been reported, 
fluoxetine has been reported in surface waters at concentrations as high as 0.012 µg/l [14] 
and in wastewater effluent from 99 µg/l [14] to 0.540 µg/l [15].  As a result, there are 
concerns over the potential sublethal effects of fluoxetine on aquatic organisms [12].  
While concentrations of pharmaceuticals have typically been found at the ng/l level, their 
presence is still a concern since they are biologically active [1].  Physiological and 
behavioral responses are among the issues raised and although the concentrations 
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detected in effluent of WWTPs are probably too low to affect humans, impacts on aquatic 
organisms are likely [10].  Pharmaceuticals may be able to biodegrade fairly quickly, but 
they are continually released into the environment simulating more chronic exposures 
than acute exposures.  Yet, little is known about the long-term low-dose chronic effects 
of exposure on aquatic organisms.  
Fluoxetine has been shown to adversely affect numerous aquatic organisms; 
however, this occurs at levels at least an order of magnitude higher than reported in the 
environment [5, 16-18].  Most results reported are that of acute toxicity tests, and many 
pharmaceuticals are not acutely toxic to aquatic organisms at low concentrations; but they 
could have significant cumulative effects [3]. Current toxicity-screening data for drugs 
are usually obtained from standard bioassays that do not target the mode of action of the 
compound [1], so the danger of some of these drugs could be, and have been, 
underestimated [19].  
Previous research in our lab, demonstrated a linear response between serotonin 
levels and feeding behavior in hybrid striped bass following a 6-day fluoxetine exposure 
[20].  However, fluoxetine concentrations used were not environmentally relevant.  The 
purpose of this study was to examine the biochemical and behavioral effects of fluoxetine 
on the feeding behavior of hybrid striped bass at lower exposure concentrations over a 
27-day period.  
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Materials and Methods 
Test chemicals 
 Fluoxetine hydrochloride, was generously donated by Fermion  (Finland). 0.1N 
perchloric acid (aq), was purchased from VWR (USA).  Methanol, acetone, 
triethylamine, acetolnitrile, glacial acetic acid, monochloro-acetic acid, and 
tetrahydrofuran were purchased from Fisher Scientific (USA).  Sodium hydroxide, 
sodium octyl sulfate, ethylenediaminetetraacetic acid (EDTA) disodium salt, 3,4-
dihydroxybenzylamine hydrobromine (DHBA), 5-hydroxyindole-3-acetic acid (5-HIAA), 
serotonin creatinine sulfate monohydrate (5-HT), norepinephrine hydrochloride (NE), 
and dopamine hydrochloride (DA) were purchased from Sigma-Aldrich (USA).  
Fish 
 Hybrid striped bass were obtained from Southland Fisheries near Columbia, SC.  
Fish were housed in 450 L circular flow-through holding tanks at Clemson University‟s 
Institute of Environmental Toxicology and fed a pellet food (Zeigler Brothers, Gardners, 
PA) daily.  Larval fathead minnows (Pimephales promelas) were obtained from a culture 
maintained at Clemson University Institute of Environmental Toxicology and reared until 
they were the appropriate size (4 to 5 cm) to be used in the tests. 
Experimental design 
Hybrid striped bass were exposed to fluoxetine for 27 days under static 
conditions, with a 50% water change every sixth day.  Bass were fed every third day on 
days 0, 3, 6, 9, 12, 15, 18, 21, 24, and 27 and feeding behavior was quantified at these 
times.  Four tests were conducted for 6, 12, 21, or 27 days, where bass were fed every 
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third day and brains harvested on days 0, 6, 12, 21, or 27, respectively, for quantification 
of brain monoamine levels. 
Hybrid striped bass (16 - 18 months old; average weight 239.8 ± 46.2 g; average 
length: 24.1 ± 1.4 cm) were randomly placed individually (one bass per tank) into 
twenty-four 80-L aquaria operated under flow-through conditions (0.23 liters per minute).  
Bass were allowed to acclimate in aquaria for five days prior to test initiation.  A nearby 
lake, Lake Hartwell (SC, USA), was the source of test waters (pH = 6.5 ± 0.8, Hardness 
24 mg/L as CaCO3, Alkalinity 10 mg/L as CaCO3).  Water was pumped through a multi-
resin filtration system (Water and Power Technologies, Columbia, SC) to remove 
suspended solids prior to entering experimental tanks. Water temperature was controlled 
using a mixing valve (M & M Control Services, Grayslake, IL) that regulated a mixture 
of ambient and chilled water (ambient water circulated through an in-line chiller) or 
heated water (ambient water circulated through an in-line heater) depending on the 
ambient conditions (summer or winter months, respectively) to facilitate achieving a 
desired temperature of about 25C.  During the exposure period while waters were static, 
water temperatures equilibrated to room temperatures (22.1 ± 1.3 C).   
 Bass were fed four fathead minnows every third day during the acclimation 
period.  This feeding regime ensured the bass were hungry and were accustomed to 
eating live minnows. Bass were fed on days 2 and 5 of the acclimation period in the 
aquaria so that the last day of acclimating coincided with day 0 of the fluoxetine 
exposure.  Feeding behavior (time to capture prey) of hybrid striped bass was then 
quantified every third day during each test. 
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Prior to a feeding time point, air stones were removed from each tank.  Four 
fathead minnows were dropped into an experimental tank and the time to eat each prey 
was recorded.  Minnows of similar size (approximately 4 to 5 cm) were pre-selected prior 
to feeding to ensure that no extremely large or small minnows were used to skew appetite 
satiation. Minnows were then randomly selected and fed to bass without regard to 
treatment.  Bass that did not eat all four minnows prior to exposure initiation were 
eliminated from the test to reduce any confounding factors. Bass were observed until all 
minnow‟s were consumed or for a maximum of 25 minutes.  Any uneaten minnows after 
25 minutes were removed from the tank prior to replacing air stones.  For statistical 
purposes, an uneaten minnow was assigned a value of 1500 seconds (25 minutes).  
Fluoxetine exposure 
Treatments of four nominal fluoxetine concentrations (0, 0.1, 1, 10 µg/l) were 
conducted with five replicate tanks per treatment.  At test initiation, water flows were 
turned off and an appropriate quantity of fluoxetine stock was added to each aquarium.  
Every three days, fluoxetine powder was weighed out and dissolved in 5 ml of methanol.  
This was used to spike three 2-liter stock solutions at various concentrations, one for each 
treatment level.  Methanol volumes ranged from 17.0 to 71.9 µl in the Low stock 
solutions up to 1, 400 to 3,300 µl in the High stock solutions.  Volumes of 100-250 ml 
from each stock were added to each individual tank to achieve the desired fluoxetine 
concentration.  Final methanol volumes did not exceed 412.5 µl in 80 L of water in test 
aquaria.  The toxicity of methanol to fish has been shown to be greater than 15,000 mg/l 
[21], and the ASTM standard guide for conducting early life-stage toxicity tests with 
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fishes  (ASTM E1241-92) allows methanol as a carrier solvent at concentrations less than 
0.1 mg/l.  In our experimental setup, methanol concentrations were much lower than this 
limit.   
Fluoxetine half-life was previously determined to be approximately 72 hours 
under test conditions.  Therefore, waters were spiked every third day with either half 
original fluoxetine concentration (days 3, 9, 15, and 21) or two-thirds the original 
fluoxetine concentration (days 6, 12, 18, and 21) when there was also a 50% water 
change.  Since exposure concentrations were so low, it was not feasible to analytically 
measure individual tank concentrations.  Therefore, the stock solutions were used for 
fluoxetine analyses.  For the low, medium, and high stock solutions, 700, 200, and 25 ml, 
respectively, were acidified to pH ~ 2.5 before being filtered through 6 ml C18 solid phase 
extraction columns (PrepSep™, Fisher Scientific, USA) that were preconditioned with 6 
ml acetone, 6 ml methanol, and 6 ml deionized water.  Extraction columns were dried for 
at least 30 minutes at room temperature on a vacuum manifold (JT Baker, Philipsburg, 
NJ) before eluting fluoxetine with10 ml methanol / 1% acetic acid.  Samples were stored 
at -20C until analyzed by HPLC-fluorescence. 
Fluoxetine Analysis 
Aqueous fluoxetine concentrations were determined on Waters 1525 Breeze 
HPLC pump with a Waters 717 Plus autosampler and Waters 2475 multi-wavelength 
fluorescence detector (Waters, Milford, MA).  Mobile phase was composed of 350 ml 
acetonitrile, 650 ml water, and 4 ml triethylamine.  Mobile phase was adjusted to pH 4 
with glacial acetic acid.  Flow rate was set at 1 ml/min for a 40 µl injection, and the 
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Alltech Prevail C18 column (150 mm, 4.66 I.D.) was set at 30C.  Fluorescence detector 
was set at 230 nm Ex/ 310 nm Em. Run time per sample was approximately 18 minutes. 
Brain tissue preparation 
Bass were euthanized in buffered MS-222 and brains were quickly removed and 
put on dry ice prior for storage at -80C until processed.  Brains were thawed, weighted, 
and diluted in 1.0 ml 0.1N perchloric acid containing 50 pg/µl DHBA, the internal 
standard.  Samples were then homogenized for 20 seconds by ultrasonic disruption and 
centrifuged at 21,000 rpm and 4C for 20 minutes to remove cellular debris.  Supernatant 
was aliquoted and stored at -80C until used for analyses. 
Protein Assay  
Protein concentrations were determined using a BCA™ Protein Assay Kit (Pierce, 
Rockford, IL, USA).  Brain homogenates were diluted 1:4 in 0.1N perchloric acid prior to 
running the assay. Brain monoamine levels were normalized using protein 
concentrations. 
Monoamine Analysis 
Brain samples were analyzed via HPLC with an electrochemical detector with 
methods modified from Lin and Pivorun [22].  The chromatographic system consisted of 
a Bioanalytical System LC-4C amperometric detector, PM-80 pump, and a C18 reverse-
phase column (ODS-2 Hypersil 250 mm x 4.6 mm).  Aliquots of 30 µl were injected into 
the sample loop (20 µl) of a rotary injection valve.  Flow rate was 1.0 ml/min, with the 
electrode potential maintained at +0.8 volts versus Ag/AgCl.  Mixed monoamine 
standards was prepared with NE, DA, 5-HIAA, and 5-HT ranging from 150 pg/µg to 10 
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pg/µg in 0.1N perchloric acid.  Each standard also contained 50 pg/µl DHBA as the 
internal standard. Each sample run took 35 minutes. 
The mobile phase consisted of 14.2 g monochloroacetic acid, 4.7 g sodium 
hydroxide, 10.0 mg disodium EDTA, 150 mg sodium octyl sulfate dissolved in 967 mL 
Milli-Q water with 15 ml of methanol and 18 ml of tetrahydrofuran.  The mobile phase 
was filtered through a 0.45 µm white nylon Millipore filter before adding methanol and 
tetrahydrofuran.  The mobile phase was degassed via sonication prior to use.  
Data analysis 
Data for time to capture prey was analyzed using Statistical Analysis Software 9.1 
(SAS; Cary, NC, USA) with two-factor ANOVA (analysis of variance) models utilizing 
treatment and day as the independent variables.  Since the time to capture prey data were 
non-normally distributed with non-homogeneous variances, PROC GLIMMIX (General 
Linear Model for Mixture Distributions), an analyses matrix that accounts for non-
normality and non-homogeneous variances, was used to perform multiple pair-wise 
comparisons.  The LSMEANS statement in PROC GLIMMIX was used to differentiate 
statistical differences across and within treatment, day, and treatment-by-day interactions. 
Monoamine concentrations were analyzed using two-factor ANOVA models 
utilizing treatment and day as the independent variables.  Although monoamine data were 
normally distributed with homogeneous variance, PROC GLIMMIX with LSMEANS 
statement was executed to differentiate statistical differences among and within the 
independent variables (treatment, day, and the treatment-by-day interaction terms) rather 
than separate LSMEANS statements within PROC GLM (ANOVA analyses) by day or 
 92 
treatment.  An  = 0.05 was used with both time to capture prey and monoamine analyses 
when examining statistical significance of factors using PROC ANOVA and PROC 
GLIMMIX. 
Results 
Fluoxetine concentrations  
Measured fluoxetine stock concentrations (mean ± standard deviation) throughout 
the exposure period for the low (0.1 µg/l), medium (1 µg/l) and high (10 µg/l) treatments 
were 0.08 ± 0.02, 0.87 ± 0.12, and 9.44 ± 0.82 µg/l, respectively. 
5-HT levels 
 There was no clear dose-response relationship for serotonin levels on any day.  As 
compared to controls on day 27, serotonin levels were significantly greater in bass in the 
high treatment (Table 1, Figure 1a).  At no other time point did fluoxetine-treated bass 
have significantly different serotonin levels as compared to the controls. When analyzing 
serotonin levels within each treatment across days, there were no significant increases or 
decreases in serotonin levels, with the exception of the medium treatment group between 
days 6 and 27 where serotonin levels were significantly greater on day 6 than day 27 
(Table 1).  In addition, serotonin levels were significantly lower in the control and low 
treatments on day 27 as compared to all other time points for these treatments (Table 1).  
In trying to explain this decrease in serotonin levels, brain monoamines in the medium 
treatment were also lower on day 27, although not significant, suggesting a possible issue 
with sample storage from that experiment, rather than a consequence of fluoxetine 
exposure. Therefore, it is not possible to conclude that the significant difference in 
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serotonin levels between the controls and high treatment on day 27 is a result of 
fluoxetine exposure. 
5-HIAA levels   
There were significant decreases in 5-HIAA levels between days 0 and 6 for bass 
in the control, low, and high treatments, but not the medium treatment (Table 1). There 
were also significant decreases in 5-HIAA levels on day 27 as compared to day 0 for all 
treatment groups, including the controls (Table 1).  This may be the result of an error in 
sample storage rather than an observed effect of fluoxetine exposure since there were 
significant changes in the controls as well.  On days 6, 12, and 21, 5-HIAA levels were 
significantly reduced in the high treatment as compared to the controls on the same day 
(Table 1, Figure 1b). There was a decreasing trend in 5-HIAA levels between days 6 and 
12 in the low and medium treatments, but they were not significant (Table 1).   By day 
27, there was no significant difference in 5-HIAA activities between any treatment 
groups.  
5-HIAA:5-HT ratio 
 On day 0, the 5-HIAA:5-HT ratio was significantly greater than all other time 
points, except for controls on day 27 (Table 1, Figure 1c).  This is most likely due to the 
significantly greater 5-HIAA levels on day 0.  Otherwise, the only significant difference 
as compared to control was seen in the high treatment on days 6 and 12 (Table 1, Figure 
1c).  However, there were no significant changes in 5-HIAA:5-HT ratio in the high 
treatment as the exposure duration continued between days 6 and 27. 
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NE levels   
There was no significant difference in NE levels as compared to controls on any 
day, with the exception of day 27 in which NE levels in the high treatment were 
significantly greater than control and low treatments (Table 1, Figure 2a).  This was most 
likely due to the significantly lower NE levels in the control and low treatments as 
compared to any other day, and not the result of fluoxetine exposure.  NE levels in bass 
in the medium treatment were significantly lower on day 27 as compared to days 0 and 6; 
however, NE levels were not as low as the control or low treatments, nor were they 
significantly different (Table 1).   
DA levels 
There were no significant differences in DA levels as compared to controls on any 
day (Table 1, Figure 2b).  However, as mentioned for the other monoamines investigated, 
there were significant declines in DA levels on day 27 in the control and low treatment 
groups as compared to any other day (Table 1). 
Behavior data 
In general, time to capture prey was not significantly impaired at the fluoxetine 
concentrations chosen for this test (Figure 3). There were, however, a few significant 
increases in time to capture prey in the high treatment as compared to controls.  Time to 
eat prey 1 was significantly longer on days 6, 15, and 24; time to eat prey 2 was 
significantly longer on days 6 and 15; time to eat prey 3 was significantly longer on days 
6, 12, and 15.  These significant differences are most likely the result of a few outlier 
bass, by which their increased time to eat greatly skewed the means.  When looking at the 
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effect of exposure-duration on each treatment, there were no significant differences 
across days, including in the high treatment.  Overall, the feeding behavior of bass was 
not affected at the concentrations tested. See Appendix Table A-3 for mean ± SE values 
for time to capture prey for each treatment and day.  
Discussion 
Selective serotonin reuptake inhibitors have become very popular due to their 
effectiveness in treating depression, obsessive-compulsive disorders, and eating 
disorders.  In 2008, there were seven identified antidepressants among the top 200 most 
prescribed drugs in the US that regulate the reuptake of serotonin on the presynaptic 
terminal (rxlist.com, 2008).  This includes both SSRIs and selective serotonin and 
norepinephrine reuptake inhibitors (SSNRIs).  Although detected environmental 
concentrations of individual SSRIs are low, the aquatic exposure might be a function of 
their combined concentrations, taking into consideration that SSRIs likely have the same 
mode of action [17].  Thus, total environmental concentrations may be approaching 
values that are shown to impact non-target species [23].  It has already been shown that 
some SSRIs can accumulate in fish in effluent-dominate streams, including fluoxetine 
[24]. 
In the laboratory, fluoxetine been shown to cause a number of behavioral effects 
in aquatic organisms including induced spawning in mussels [16], reduced reproduction 
in C. dubia [9], and reduced feeding behavior in hybrid striped bass [20].  However, all 
these results were determined using fluoxetine concentrations that were greater than what 
is found in the environment.  When looking at the effects at lower, more environmentally 
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relevant concentrations, the effects were not as profound.  In the present study, we saw no 
significant effects of fluoxetine on feeding behavior in bass exposed to 0.1 1.0, or 10.0 
µg/l over the 27-day exposure.  There were a few time points in which feeding behavior 
in the highest treatment was significantly different from controls, but it cannot be 
concluded if this was a result of fluoxetine exposure, or just individual variability. 
Overall, there was no clear dose-dependent response in feeding behavior across treatment 
for any time point.  
It has been generally concluded that environmentally relevant concentrations of 
fluoxetine is not likely to cause acute toxicity to aquatic organisms.  However, as a result 
of the continuous human use of fluoxetine and the incomplete removal of SSRIs and 
other pharmaceuticals from WWTPs, there will likely be a continuous release of low 
concentrations into the environment [17].  Therefore, chronic toxicity tests to determine 
long-term effects should be routine when evaluating these chemicals. Henry and Black 
[18] found that chronic exposure of western mosquitofish (Gambusia affinis) to low 
concentrations of fluoxetine did not affect survival, sex ratio, or development.  While 
there was evidence of decreased expression of sexual characteristics indicating 
developmental delays from chronic fluoxetine exposure of 71 µg/l, this effect was not 
seen at lower tested concentrations [18].  Other long-term tests conducted using low 
fluoxetine concentrations (0.1 to 5.0 µg/l) showed no effect on growth or condition 
factors, or a number of measured adult reproductive parameters in Japanese medaka 
(Oryzias latipes) [25].  In addition, long-term fluoxetine treatment (14 daily i.p. injections 
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at 4.3 mmol) of male Betta spendens did not significantly decrease their territorial 
aggression [26].  
The results of the present study further support the notion that there are minimal 
effects of long-term fluoxetine exposure on behavior.  There were no clear behavioral 
effects on feeding as a result of exposure duration in bass exposed to fluoxetine (0.1 to 
10.0 µg/l) for 27 days.  In the high treatment there were some observed behavioral effects 
of fluoxetine in which some bass were slightly diagonal in the water column, but this did 
not impair their ability to capture prey once minnows were dropped into the aquarium.  
Bass in all treatments, including the high treatment, were observed to be anxiously 
waiting to be fed.  Contrary to our observations, Henry and Black[18] noted that there 
was a slight increase in lethargy when mosquitofish were chronically exposed to 
fluoxetine (0.5 to 5.0 µg/l), indicating slight behavioral changes [18].  However, this 
could be attributed to differences in species sensitivity.  
Serotonin is involved in a number of physiological processes, including control of 
meal size or satiation, and fluoxetine has been shown to have properties of satiety 
enhancing agents, advancing the behavioral satiety sequence in rats [8].  Thus fluoxetine 
exposure has the potential to alter serotonin levels and hunger in aquatic species as well, 
ultimately resulting in consequences on organism and population [17].  Unfortunately, 
attempts to provide a unified function for serotonin are elusive since the literature on this 
one chemical system is filled with apparent contradictions [11] with species to species 
variability including teleosts [27]. 
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While fluoxetine was developed with the intent to increase serotonin levels at the 
synapse, there is a delayed onset of this therapeutic effect for 2-4 weeks [28, 29].  As a 
compensatory mechanism following the blockage of reuptake pumps, inhibitory 5-HT 
autoreceptors are activated leading to decreased serotonin neuronal activity and 
neurotransmitter release, thus preventing an increase in serotonin concentrations [30].  It 
has been shown that desensitization of 5-HT1A and 5-HT1B autoreceptors that control 
serotonin release occurs after long-term treatment with SSRIs [28-30], thus eventually 
allowing the release of serotonin while in the presence of SSRIs.  This process leads to 
the delayed therapeutic effect.   
Many aquatic toxicity tests involving fluoxetine are preformed without verifying 
changes in serotonin levels in the organism, assuming that serotonin levels would 
increase in the presence of fluoxetine.  One rat study involving fluoxetine noted elevated 
serotonin levels within 30 minutes of exposure and persisted for four hours [31], but they 
did not continue monitoring serotonin levels past this point.  Since fluoxetine binds 
immediately to the transporters [32], it may be possible that this initial increase in 
serotonin levels occurred before autoreceptors were desensitized. When we looked at 
serotonin levels three and six days following the initial fluoxetine exposure in bass, we 
found that bass exhibited a decrease in serotonin levels [20].  We attributed this to 
activated 5-HT autoreceptors that decreased the release of serotonin into the synapse.  We 
hypothesized that if we carried out the exposure over a longer period of time, we would 
possibly see serotonin levels return to control levels and maybe surpass control serotonin 
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levels.  However, at the fluoxetine concentrations used in the present study, we did not 
observe this effect.   
While there was a decrease in serotonin levels on day 12 of the fluoxetine 
exposure, it was neither dose-dependent nor significant. In addition, we did see 
significantly elevated serotonin levels in the high treatment group as compared to 
controls on day 27 and it may be an effect of the long-term fluoxetine exposure, but it is 
also possible that this is the result of unusually low monoamine levels in the control and 
low treatment groups on that day.  There were no significant changes in serotonin levels 
in the high treatment at any time points tested (days 0, 6, 12, 21, and 27), so the latter 
may be true.  Differences in basal monoamine levels observed among experiments were 
likely a result of the fact that each experiment was conducted at different times and 
sample preparations were not conducted all at the same time. Additional research would 
need to be performed to further speculate the effects of fluoxetine exposure on hybrid 
striped bass.   
Since 5-HIAA is the metabolite of serotonin, there would also be a decrease in 5-
HIAA levels noted in the presence of fluoxetine since there is less serotonin at the 
synapse until the autoreceptors are desensitized.  In the present study, there was 
significantly less 5-HIAA in bass in the high treatment as compared to controls on days 6, 
12, and 21. This would be consistent with a decreased firing of 5-HT neurons due to the 
activation of autoreceptors in the presence of fluoxetine, but there was not a decrease in 
serotonin levels to fully support this conclusion.  
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Other studies in mice have shown a reduction in the 5-HIAA:5-HT ratio after 
acute, subacute, and chronic treatments [33].  They noted a persistence of decreased 
serotonin turnover (5-HIAA:5-HT) during the fluoxetine administration.  In the present 
study, there were significant decreases in serotonin turnover noted as compared to 
controls, but only differences on days 6 and 21 in the high treatment.  It is also important 
to mention here that there was no significant change in serotonin turnover in the high 
treatment between days 6 and 27.  The serotonin turnover rate (5-HIAA:5-HT ratio) was 
significantly higher on day 0 as compared to any other day, but this is most likely the 
result of the high basal levels of 5-HIAA on that day.  
Although it is supposed to be selective for serotonin, fluoxetine exposure has been 
shown to increase extracellular norepinephrine and dopamine in rats [31].  In the present 
study, there were no significant differences in norepinephrine or dopamine levels in bass 
treated with fluoxetine as compared to the controls, with the exception on day 27.  Bass 
in the high treatment exhibited significantly greater norepinephrine levels as compared to 
the control and low treatments and significantly greater dopamine levels than the low 
treatment, but not controls, on that day.  Again, we cannot confirm whether these findings 
were a result of the fluoxetine exposure, or a result the significant decrease monoamine 
levels in the control and low treatments on that day as compared to all other time points.  
While it is important to determine the effects of fluoxetine on aquatic organisms 
at environmentally relevant concentrations, it is also important to know what effects 
could occur at higher exposure concentrations.  Individual pharmaceuticals occurring at 
low levels in the environment may exhibit synergistic and cumulative effects [3].  Using 
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only standardized tests, the effects of pharmaceuticals in the environment could be 
underestimated.  Since the FDA is not entirely concerned with drugs present in the 
environment below 1 µg/l, additive effects of drugs with similar modes of action, and 
interactions of drugs with different modes of actions are not considered [5].  If tests were 
tailored toward the mode of action of a compound, the effects level could be significantly 
lowered [19].  
While regulations for drugs in the environment are only beginning to be 
considered, they are no different from other chemicals.  They still have the potential to 
cause adverse effects to aquatic organisms and communities, especially since many are 
known to make their way through WWTPs.  Although research results have shown that 
there appears to be minimal behavioral and/or biochemical effects to individual SSRI 
exposure scenarios, this should not be interpreted to suggest there are no effects of 
exposure. It is likely that continual pharmaceutical exposure to aquatic organisms could 
result in effects that go unnoticed until they become irreversible.  The effects could 
accumulate slowly, and as a result changes may be attributed to natural, ecological 
succession [34] rather than the problem at hand.  It is important to run chronic exposure 
tests, recognizing that most pharmaceutical active ingredients are not acutely toxic, but 
may have long-term effects on organisms.  It is also important to continue expanding this 
research using mixtures of pharmaceuticals, especially those that have the same mode of 
action.  We know that individual pharmaceuticals have shown effects at concentrations 
greater than found in the environment; next we need to explore the effects of low-level 
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mixtures of SSRIs with the same speculated mode of action to more accurately rule out or 
define adverse effects of exposure to aquatic organisms. 
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Figure 4.1.  Serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) levels (mean  
SE) in hybrid striped bass brains, and 5-HIAA:5-HT ratios during a 27-day fluoxetine 
exposure.  * denotes significant differences (=0.05) from the control on the respective 
day. 
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Figure 4.2. Norepinephrine (A.) and dopamine (B.) levels (mean  SE) in hybrid striped 
bass brains during a 27-day fluoxetine exposure.  * denotes significant differences 
(=0.05) from the control on the respective day. 
0
5
10
15
20
0 6 12 21 27
Day
D
o
p
am
in
e 
(p
g
/µ
g
 p
ro
te
in
)
B.
0
20
40
60
80
0 6 12 21 27
N
o
re
p
in
ep
h
ri
n
e 
(p
g
/µ
g
 p
ro
te
in
) control low medium high
*
A.
 108 
 
 
Figure 4.3. Time (mean  SE) it took hybrid striped bass to capture prey 1, 2, and 3 
during a 27-day fluoxetine exposure.  * denotes days when time to capture prey in the 
high and medium treatments, respectively, were significantly different ( = 0.05) from 
controls. 
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Table 4.1. Serotonin (5-HT), 5- hydroxyindoleacetic acid (5-HIAA), norepinephrine 
(NE), dopamine (DA) levels (mean  SE) in hybrid striped bass (pg/µg protein), and the 
5-HIAA:5-HT ratio following a 27-day fluoxetine exposure.  a through f denotes 
significant differences among treatment and day for each monoamine or ratio. (On 
previous page) 
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CONCLUSIONS 
Behavior 
(1) There were duration-dependent increases in time-to-capture prey in hybrid striped 
bass acutely exposed to diazinon or fluoxetine for 6 days. 
(2) There were duration-dependent decreases in time-to-capture prey in hybrid striped 
bass through 6-day recovery periods following acute diazinon or fluoxetine 
exposures. 
(3) There were no concentration- or duration-dependent responses in time-to-capture 
prey in hybrid striped bass exposed to fluoxetine for 27 days. 
Biochemistry 
(4) There were concentration- and duration-dependent decreases in brain 
acetylcholinesterase (AChE) and serotonin levels in hybrid striped bass acutely 
exposed to diazinon and fluoxetine, respectively, for 6 days 
(5) There were concentration- and duration-dependent increases in brain 
acetylcholinesterase and serotonin levels in hybrid striped bass through 6-day 
recovery periods from diazinon or fluoxetine exposures, respectively. However, 
increases were not always significant nor did they all reach control levels at the 
end of the recovery period. 
(6) There were no concentration- or duration-dependent changes in serotonin, 
norepinephrine, or dopamine levels in hybrid striped bass exposed to fluoxetine 
for 27-d.  5-HIAA levels were only significantly lower than controls in the highest 
fluoxetine treatment (10 µg/L). 
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Relating feeding behavior and brain biochemistry 
(7) Feeding behavior recovered more quickly than brain AChE or serotonin activities; 
6-day recovery periods were not sufficient for full recovery of either 
neurotransmitter.   
(8) There was a threshold response between brain AChE activity and time-to-capture 
prey for hybrid striped bass acutely exposed to diazinon. 
(9) There was a linear relationship between brain serotonin levels and time-to-capture 
prey for hybrid striped bass acutely exposed to fluoxetine. 
 
The research in this dissertation demonstrated that relationships between 
biochemical and behavioral endpoints could be determined.  We found that prey capture 
is an ecologically relevant behavior that can be related to brain neurotransmitter activity.  
Recognizing that behavioral changes are likely a product of altered biochemistry and 
understanding this connection may allow more meaningful interpretations of biochemical 
biomarkers.  While there has been an increase in research characterizing various 
biomarkers, they are not routinely used in risk assessments because their ecological 
relevance is not as well defined.  So once a relationship has been defined, it may possible 
to use biomarkers as a tool for validating risk.  In addition, knowing such a relationship 
may also aid in predicting more accurately population level impacts from a biochemical 
endpoint following contaminant exposure. 
This bioassay shows potential for evaluating effects of short- and long-term 
sublethal contaminant exposures on feeding behavior, as well as the ability to monitor 
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recovery of an organism following exposure.  While we know that toxic effects may last 
longer than the original exposure, we do not usually monitor the recovery of an organism.  
But this bioasay can successfully reveal prolonged effects and/or improvements in 
feeding behavior and brain biochemistry, and the sensitivity of each.  Overall, the 
behavioral assay designed for this dissertation can increase our understanding of how 
changes in brain biochemistry may impact the feeding behavior of hybrid striped bass, 
and can be further used to understand effects of sublethal exposures to neurotoxins on 
feeding behavior.  This assay may provide a practical link between changes at the 
biochemical and population level. 
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APPENDIX 
Table A-1 
Time (mean  SE) it took hybrid striped bass to capture each of four consecutive prey 
(fathead minnows) during a 6-day diazinon exposure followed by a 6-day recovery 
period.  Control, low, medium and high treatments correspond to diazinon concentrations 
of (mean  SE) 0.7 ± 0.1, 19.6 ± 0.7, 62.9 ± 2.0, and 98.4 ± 1.4 µg/l, respectively.  
(Referenced on page 41) 
 
 
 
 
 
Prey Treatment Day 0 Day 3 Day 6 Day 9 Day 12
1 Control 4.09 (± 0.67) 4.63 (± 1.69) 1.79 (± 0.31) 5.71 (± 2.42) 4.00 (± 1.58)
Low 6.74 (± 1.72) 2.11 (± 0.30) 2.14 (± 0.27) 2.44 (± 0.44) 1.50 (± 0.29)
Medium 14.45 (± 7.35) 4.42 (± 1.07) 582.14 (± 171.21) 307.20 (± 198.83) 49.00 (± 44.36)
High 4.75 (± 1.93) 204.56 (± 126.71) 1024.17 (± 203.15) 567.75 (± 206.93) 398.25 (± 328.89)
2 Control 7.59 (± 1.71) 15.29 (± 5.35) 12.00 (± 6.65) 12.83 (± 9.44) 7.25 (± 1.89)
Low 9.84 (± 1.91) 4.05 (± 0.33) 4.07 (± 0.47 8.67 (± 3.09) 5.00 (± 1.910
Medium 21.00 (± 8.83) 264.10 (± 122.91) 931.00 (± 187.56) 362.33 (± 215.34) 168.25 (± 123.16)
High 7.00 (± 1.97) 454.69 (± 159.11) 1269.50 (± 155.91) 803.25 (± 265.50) 435.75 (± 320.60)
 
3 Control 15.88 (± 3.85) 40.06 (± 16.46) 18.00 (± 9.61) 61.33 (± 56.34) 15.50 (± 5.98)
Low 27.42 (± 7.30 12.11 (± 5.04) 13.00 (± 5.60) 14.11 (± 3.73) 10.00 (± 3.14)
Medium 86.90 (± 50.27) 404.10 (± 144.98) 1172.47 (± 155.94) 998.70 (± 228.88) 842.80 (± 332.19)
High 26.50 (± 18.92) 838.94 (± 175.12) 1383.17 (± 116.83) 1190.50 (± 219.83) 1129.50 (± 331.39)
4 Control 38.56 (± 7.85) 251.41 (± 118.65) 153.17 (± 123.06) 434.86 (± 275.02) 8.00 (± 1.00)
Low 87.53 (± 23.94) 122.95 (± 79.05) 37.57 (± 16.25) 170.89 (± 101.87) 153.00 (± 143.35)
Medium 165.45 (± 71.00) 841.55 (± 163.45) 1243.13 (± 137.58) 1067.70 (± 232.19) 1188.40 (± 246.20)
High 42.94 (± 24.78) 1080.63 (± 163.01) 1495.92 (± 4.08) 1448.57 (± 51.43) 1444.50 (± 646.00)
Time to capture prey (seconds)
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Table A-2 
Time (mean  SE) it took hybrid striped bass to capture each of four consecutive prey 
(fathead minnows) during a 6-day fluoxetine exposure followed by a 6-day recovery 
period.  Low, medium and high treatments correspond to diazinon concentrations of 
(mean  SE) 23.2 ± 6.6, 51.4 ± 10.9, and 100.9 ± 18.6 µg/l, respectively.  
(Referenced on page 67) 
 
 
 
Prey Treatment Day 0 Day 3 Day 6 Day 9 Day 12
1 Control 7.98 (± 3.45) 13.00 (± 7.14) 16.29 (± 8.56) 3.00 (± 0.95) 2.80 (± 1.11)
Low 11.27 (± 2.88) 50.79 (± 19.28) 397.00 (± 146.62) 63.58 (± 17.97) 31.60 (± 18.59)
Medium 1.57 (± 4.22) 329.67 (± 128.1) 465.56 (± 158.31) 432.18 (± 207.1) 176.80 (± 151.12)
High 18.59 (± 8.37) 808.55 (± 152.63) 878.06 (± 163.62) 1129.00 (± 190.16) 1212.00 (± 288.00)
2 Control 26.09 (± 8.79) 23.29 (± 9.2) 44.64 (± 17.58) 6.60 (± 1.85) 6.80 (± 1.83)
Low 37.45 (± 10.36) 414.00 (± 138.97) 575.25 (± 166.22) 732.27 (± 210.11) 328.60 (± 293.66)
Medium 28.19 (± 9.81) 568.95 (± 150.49) 810.19 (± 179.77) 835.75 (± 252.93) 719.40 (± 310.87)
High 37.00 (± 12.48) 1005.59 (± 139.4) 1147.94 (± 145.04) 1279.30 (± 141.39) 1216.00 (± 284.00)
 
3 Control 159.61 (± 122.84) 215.76 (± 117.6) 293.36 (±136.85) 25.70 (± 10.87) 180.00 (± 163.54)
Low 129.86 (± 29.48) 772.00 (± 148.15) 1256.92 (± 131.49) 1125 (± 186.76) 537.40 (± 310.99)
Medium 96.19 (± 31.55) 844.33 (± 156.6) 1250.00 (± 134.83) 1196.18 (± 174.39) 909.00 (± 361.93)
High 146.36 (± 41.5) 1299.55 (± 93.94) 1353.07 (± 87.51) 1500.00 (± 0.00) 1255.20 (± 244.80)
4 Control 593.04 (± 128.13) 589.18 (± 152.29) 780.93 (± 186.80) 520.00 (± 216.34) 651.60 (± 347.00)
Low 604.81 (± 126.88) 1249.95 (± 116.03) 1378.25 (± 102.29) 1144.36 (± 186.01) 1392.60 (± 107.40)
Medium 502.10 (± 126.96) 1239.00 (± 111.92) 1361.13 (± 97.41) 1257.36 (± 163.00) 1059.20 (± 285.60)
High 671.91 (± 133.37) 1419.64 (± 55.47) 1435.63 (± 64.38) 1500.00 (± 0.00) 1500.00 (± 0.00)
Time to capture prey (seconds)
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Table A-3 
Time (mean  SE) it took hybrid striped bass to capture each of four consecutive prey 
(fathead minnows) during a 27-day fluoxetine exposure.  Low, medium and high 
treatments correspond to diazinon concentrations of (mean  SE) 0.08 ± 0.02, 0.87 ± 
0.12, and 9.44 ± 0.82 µg/l, respectively.  (On next page) 
(Referenced on page 95)  
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